{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 450655, "items": [{"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:22:40Z", "timestamp": 1574144560068}, "reference-count": 38, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 2, 1]], "date-time": "2003-02-01T00:00:00Z", "timestamp": 1044057600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biochemical Pharmacology"], "published-print": {"date-parts": [[2003, 2]]}, "DOI": "10.1016/s0006-2952(02)01515-0", "type": "journal-article", "created": {"date-parts": [[2003, 1, 17]], "date-time": "2003-01-17T17:33:27Z", "timestamp": 1042824807000}, "page": "435-440", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes"], "prefix": "10.1016", "volume": "65", "author": [{"given": "Ahc\u00e8ne", "family": "Hameg", "sequence": "first", "affiliation": []}, {"given": "Franck", "family": "Bayle", "sequence": "additional", "affiliation": []}, {"given": "Philippe", "family": "Nuss", "sequence": "additional", "affiliation": []}, {"given": "Philippe", "family": "Dupuis", "sequence": "additional", "affiliation": []}, {"given": "Ricardo P.", "family": "Garay", "sequence": "additional", "affiliation": []}, {"given": "Michel", "family": "Dib", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Biochemical Pharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0006295202015150?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0006295202015150?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 2]], "date-time": "2019-04-02T10:58:57Z", "timestamp": 1554202737000}, "score": 94.41268, "issued": {"date-parts": [[2003, 2]]}, "references-count": 38, "journal-issue": {"published-print": {"date-parts": [[2003, 2]]}, "issue": "3"}, "alternative-id": ["S0006295202015150"], "URL": "http://dx.doi.org/10.1016/s0006-2952(02)01515-0", "ISSN": ["0006-2952"], "issn-type": [{"value": "0006-2952", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T08:13:54Z", "timestamp": 1574324034600}, "reference-count": 27, "publisher": "Elsevier BV", "issue": "2-3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 1, 1]], "date-time": "2008-01-01T00:00:00Z", "timestamp": 1199145600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Pharmacology"], "published-print": {"date-parts": [[2008, 1]]}, "DOI": "10.1016/j.ejphar.2007.09.025", "type": "journal-article", "created": {"date-parts": [[2007, 10, 3]], "date-time": "2007-10-03T11:12:27Z", "timestamp": 1191409947000}, "page": "142-147", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes"], "prefix": "10.1016", "volume": "578", "author": [{"given": "Amine", "family": "Benyamina", "sequence": "first", "affiliation": []}, {"given": "Christophe", "family": "Arbus", "sequence": "additional", "affiliation": []}, {"given": "Philippe", "family": "Nuss", "sequence": "additional", "affiliation": []}, {"given": "Ricardo P.", "family": "Garay", "sequence": "additional", "affiliation": []}, {"given": "Gervais", "family": "Neliat", "sequence": "additional", "affiliation": []}, {"given": "Ahc\u00e8ne", "family": "Hameg", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Pharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0014299907010539?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0014299907010539?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 3]], "date-time": "2019-05-03T13:59:31Z", "timestamp": 1556891971000}, "score": 46.639637, "issued": {"date-parts": [[2008, 1]]}, "references-count": 27, "journal-issue": {"published-print": {"date-parts": [[2008, 1]]}, "issue": "2-3"}, "alternative-id": ["S0014299907010539"], "URL": "http://dx.doi.org/10.1016/j.ejphar.2007.09.025", "ISSN": ["0014-2999"], "issn-type": [{"value": "0014-2999", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T17:28:21Z", "timestamp": 1574530101535}, "publisher-location": "Dordrecht", "reference-count": 40, "publisher": "Springer Netherlands", "isbn-type": [{"value": "9789401048491", "type": "print"}, {"value": "9789401119207", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1993, 1, 1]], "date-time": "1993-01-01T00:00:00Z", "timestamp": 725846400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1993]]}, "DOI": "10.1007/978-94-011-1920-7_26", "type": "book-chapter", "created": {"date-parts": [[2011, 7, 27]], "date-time": "2011-07-27T01:00:20Z", "timestamp": 1311728420000}, "page": "223-230", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Anxiolytic Effects of Drugs Acting on 5-HT Receptor Subtypes"], "prefix": "10.1007", "author": [{"given": "D. L.", "family": "Murphy", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Broocks", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Aulakh", "sequence": "additional", "affiliation": []}, {"given": "T. A.", "family": "Pigott", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "26_CR1", "first-page": "41", "volume": "27", "author": "AG Romero", "year": "1989", "unstructured": "Romero, A.G. and McCall, R.B. (1989) \u2018Advances in central serotonergics\u2019, Ann. Rep. Med. Chem. 27, 41\u201350.", "journal-title": "Ann. Rep. Med. Chem."}, {"key": "26_CR2", "first-page": "53", "volume": "51", "author": "DL Murphy", "year": "1990", "unstructured": "Murphy, D. L. and Pigott, T. A. (1990) \u2018A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety\u2019, J. Clin. Psychiatry 51, 53\u201358.", "journal-title": "J. Clin. Psychiatry"}, {"key": "26_CR3", "doi-asserted-by": "publisher", "first-page": "437", "DOI": "10.1146/annurev.me.41.020190.002253", "volume": "41", "author": "DS Charney", "year": "1990", "unstructured": "Charney, D. S., Krystal, J. H., Delgado, P. L., and Heninger, G. R. (1990) \u2018Serotonin-specific drugs for anxiety and depressive disorders\u2019, Annu. Rev. Med. 41, 437\u2013446.", "journal-title": "Annu. Rev. Med."}, {"key": "26_CR4", "doi-asserted-by": "publisher", "first-page": "15", "DOI": "10.1016/0143-4179(91)90078-W", "volume": "19", "author": "DP Taylor", "year": "1991", "unstructured": "Taylor, D. P. and Moon, S. L. (1991) \u2018Buspirone and related compounds as alternative anxiolytics\u2019, Neuropeptides 19, 15\u201319.", "journal-title": "Neuropeptides"}, {"key": "26_CR5", "doi-asserted-by": "publisher", "first-page": "7", "DOI": "10.1192/bjp.159.3.341", "volume": "159", "author": "PJ Cowen", "year": "1991", "unstructured": "Cowen, P. J. (1991) \u2018Serotonin receptor subtypes: Implications for psychopharmacology\u2019, Br. J. Psychiatry 159, 7\u201314.", "journal-title": "Br.J.Psychiatry"}, {"key": "26_CR6", "doi-asserted-by": "publisher", "first-page": "26S", "DOI": "10.1097/00004714-199006001-00006", "volume": "10", "author": "MS Eison", "year": "1990", "unstructured": "Eison, M. S. (1990) \u2018Serotonin: A common neurobiologic substrate in anxiety and depression\u2019, J. Clin. Psychopharmacology 10, 26S\u201330S.", "journal-title": "J. Clin. Psychopharmacology"}, {"key": "26_CR7", "first-page": "457", "volume": "3", "author": "DL Murphy", "year": "1990", "unstructured": "Murphy, D. L. (1990) \u2018Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems\u2019, Neuropsychopharmacology 3, 457\u2013471.", "journal-title": "Neuropsychopharmacology"}, {"key": "26_CR8", "doi-asserted-by": "publisher", "first-page": "149", "DOI": "10.1111/j.1600-0773.1991.tb01289.x", "volume": "69", "author": "G Tunnicliff", "year": "1991", "unstructured": "Tunnicliff, G. (1991) \u2018Moleuclar basis of buspirone\u2019s anxiolytic action\u2019, Pharmacol. Toxicol. 69, 149\u2013156.", "journal-title": "Pharmacol. Toxicol."}, {"key": "26_CR9", "author": "E Schweizer", "first-page": "365", "year": "1991", "unstructured": "Schweizer, E. and Rickels, K. (1991) \u2018Serotonergic anxiolytics: A review of their clinical efficacy\u2019, in R. J. Rodgers, S. J. Cooper (eds.), 5-HT,\u201e Agonists, 5-HT, Antagonists and Benzodiazcpines, John Wiley and Sons, New York, pp. 365\u2013376.", "volume-title": "5-HT,\u201e Agonists, 5-HT, Antagonists and Benzodiazcpines"}, {"key": "26_CR10", "first-page": "3", "volume": "51", "author": "SL Dubovsky", "year": "1990", "unstructured": "Dubovsky, S. L. (1990) \u2018Generalized anxiety disorder: New concepts and psychopharmacologie therapies\u2019, J. Clin. Psychiatry 51, 3\u201310.", "journal-title": "J. Clin. Psychiatry"}, {"key": "26_CR11", "first-page": "31", "volume": "52", "author": "TW Uhde", "year": "1991", "unstructured": "Uhde, T. W., Tancer, M. E., Black, B., and Brown, T. M. (1991) \u2018Phenomenology and neurobiology of social phobia: Comparison with panic disorder\u2019, J. Clin. Psychiatry 52, 31\u201340.", "journal-title": "J. Clin. Psychiatry"}, {"key": "26_CR12", "first-page": "31", "volume": "174A", "author": "A Broocks", "year": "1992", "unstructured": "Broocks, A., Pigott, T. A., Canter, S., Grady, T. A., L\u2019Heureux, F., Hill, J. L., and Murphy, D. L. (1992) \u2018Acute administration of ondansetron and mCPP in patients with obsessive-compulsive disorder (OCD) and controls: Behavioral and biological results\u2019, Biol. Psychiatry 31, 174A.", "journal-title": "Biol. Psychiatry"}, {"key": "26_CR13", "first-page": "185", "volume": "81", "author": "D Laws", "year": "1990", "unstructured": "Laws, D., Ashford, J. J., and Anstee, J. A. (1990) \u2018A multicentre double-blind comparative trial of fluvoxamine versus lorazepam in mixed anxiety and depression treated in general practice\u2019, Acta Psychiatr. Scand. 81, 185\u2013189.", "journal-title": "Scand."}, {"key": "26_CR14", "first-page": "34", "volume": "52", "author": "K Rickels", "year": "1991", "unstructured": "Rickels, K., Amsterdam, J. D., Clary, C., Puzzuoli, G., and Schweizer, E. (1991) \u2018Buspirone in major depression: A controlled study\u2019, J. Clin. Psychiatry 52, 34\u201338.", "journal-title": "J. Clin. Psychiatry"}, {"key": "26_CR15", "doi-asserted-by": "publisher", "first-page": "293", "DOI": "10.1097/00004714-199208000-00022", "volume": "12", "author": "B Black", "year": "1992", "unstructured": "Black, B., Uhde, T. W., and Tancer, M. E. (1992) \u2018Fluoxetine for the treatment of social phobia\u2019, J. Clin. Psychopharmacol. 12, 293\u2013295.", "journal-title": "J. Clin. Psychopharmacol."}, {"key": "26_CR16", "doi-asserted-by": "publisher", "first-page": "300", "DOI": "10.1097/00004714-199208000-00027", "volume": "12", "author": "BJ Cox", "year": "1992", "unstructured": "Cox, B. J., Swinson, R. P., and Lee, P. S. (1992) \u2018Meta-analysis of anxiety disorder treatment studies\u2019, J. Clin. Psychopharmacol. 12, 300\u2013301.", "journal-title": "J. Clin. Psychopharmacol."}, {"key": "26_CR17", "author": "DS Robinson", "first-page": "3", "year": "1991", "unstructured": "Robinson, D. S. (1991) \u2018Buspirone in the treatment of anxiety\u2019, in G. Tunnicliff, A. A. Eison, D. P. Taylor (eds.), Mechanism and Clinical Aspects, Academic Press, San Diego, pp. 3\u201317.", "volume-title": "Mechanism and Clinical Aspects"}, {"key": "26_CR18", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1097/00004714-199002000-00002", "volume": "10", "author": "DV Sheehan", "year": "1990", "unstructured": "Sheehan, D. V., Raj, A. B., Sheehan, K. H., and Soto, S. (1990) \u2018Is buspirone effective for panic disorder?\u2019, J. Clin. Psychopharmacol. 10, 3\u201311.", "journal-title": "J. Clin. Psychopharmacol."}, {"key": "26_CR19", "doi-asserted-by": "publisher", "first-page": "60", "DOI": "10.1159/000284627", "volume": "22", "author": "R Pohl", "year": "1989", "unstructured": "Pohl, R., Baton, R., Yeragani, V. K., and Gershon, S. (1989) \u2018Serotonergic anxiolytics in the treatment of panic disorder: A controlled study with buspirone\u2019, Psychopathology 22, 60\u201367.", "journal-title": "Psychopathology"}, {"key": "26_CR20", "doi-asserted-by": "crossref", "first-page": "127", "DOI": "10.1176/ajp.148.1.127", "volume": "148", "author": "MT Pato", "year": "1991", "unstructured": "Pato, M. T., Pigott, T. A., Hill, J. L., Grover, G. N., Bernstein, S., and Murphy, D. L. (1991) \u2018Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder\u2019, Am. J. Psychiatry 148, 127\u2013129.", "journal-title": "Am. J. Psychiatry"}, {"key": "26_CR21", "doi-asserted-by": "publisher", "first-page": "68", "DOI": "10.1159/000284628", "volume": "22", "author": "HGM Westenberg", "year": "1989", "unstructured": "Westenberg, H. G. M. and denBoer, J. A. (1989) \u2018Serotonin-influencing drugs in the treatment of panic disorder\u2019, Psychopathology 22, 68\u201377.", "journal-title": "Psychopathology"}, {"key": "26_CR22", "first-page": "431", "volume": "17", "author": "\u2018Ritanserin\u2019", "year": "1992", "unstructured": "\u2018Ritanserin\u2019, (1992) xxxDrugs Fut. 17, 431\u2013433.", "journal-title": "Drugs Fut"}, {"key": "26_CR23", "first-page": "89", "volume": "102", "author": "JA denBoer", "year": "1990", "unstructured": "denBoer, J. A. and Westenberg, H. G. M. (1990) \u2018Serotonin function in panic disorder: A double blind placebo controlled study with fluvoxamine and ritanserin\u2019, Psychopharmacology 102, 89\u201394.", "journal-title": "Psychopharmacology"}, {"key": "26_CR24", "first-page": "156", "volume": "12", "author": "TA Pigott", "year": "1992", "unstructured": "Pigott, T. A., L\u2019Heureux, F., Rubenstein, C. S., Bernstein, S. E., Hill, J. L., and Murphy, D. L. (1992) \u2018A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder\u2019, J. Clin. Psychopharmacol. 12, 156\u2013162.", "journal-title": "J. Clin. Psychopharmacol."}, {"key": "26_CR25", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1111/j.1600-0773.1992.tb00448.x", "volume": "70", "author": "B Costal!", "year": "1992", "unstructured": "Costal!, B. and Naylor, R. J. (1992) \u2018Anxiolytic potential of 5-HT, receptor antagonists\u2019, Pharmacol. Toxicol. 70, 157\u2013162.", "journal-title": "Pharmacol. Toxicol."}, {"key": "26_CR26", "author": "DL Murphy", "year": "1993", "unstructured": "Murphy, D. L., Pigott, T. A., Grady, T. A., Broocks, A., and Altemus, M. (1993), \u2018Neuropharmacological investigations of brain serotonin subsystem functions in obsessive-compulsive disorder\u2019, in P.B. Bradley, et al. (eds.), Serotonin, CNS Receptors and Brain Function, Pergamon Press, Oxford, U.K., in press.", "volume-title": "Serotonin, CNS Receptors and Brain Function"}, {"key": "26_CR27", "doi-asserted-by": "publisher", "first-page": "251", "DOI": "10.1097/00004714-199208000-00007", "volume": "12", "author": "K Modigh", "year": "1992", "unstructured": "Modigh, K., Westberg, P., and Eriksson, E. (1992) \u2018Superiority of clomipramine over imipramine in the treatment of panic disorder: A placebo-controlled trial\u2019, J. Clin. Psychopharmacol. 12, 251\u2013261.", "journal-title": "J. Clin. Psychopharmacol."}, {"key": "26_CR28", "doi-asserted-by": "publisher", "first-page": "59", "DOI": "10.1097/00004850-198801000-00005", "volume": "3", "author": "JA Boer den", "year": "1988", "unstructured": "denBoer, J. A. and Westernberg, H. G. (1988) \u2018Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder\u2019, Int. Clin. Psychopharmacol. 3, 59\u201374.", "journal-title": "Int. Clin. Psychopharmacol."}, {"key": "26_CR29", "doi-asserted-by": "publisher", "first-page": "21", "DOI": "10.1016/0006-3223(90)90428-5", "volume": "28", "author": "SD Targum", "year": "1990", "unstructured": "Targum, S. D. (1990) \u2018Differential responses to anxiogenic challenge studies in patients with major depressive disorder and panic disorder\u2019, Biol. Psychiatry 28, 21\u201334.", "journal-title": "Biol. Psychiatry"}, {"key": "26_CR30", "doi-asserted-by": "publisher", "first-page": "379", "DOI": "10.1007/BF02245165", "volume": "107", "author": "GA Kennett", "year": "1992", "unstructured": "Kennett, G. A. (1992) \u20185-HT,, receptor antagonists have anxiolytic-like actions in the rat social interaction model\u2019, Psychopharmacology 107, 379\u2013384.", "journal-title": "Psychopharmacology"}, {"key": "26_CR31", "first-page": "527", "volume": "43", "author": "DL Murphy", "year": "1991", "unstructured": "Murphy, D. L., Lesch, K. P., Aulakh, C. S., and Pigott, T. A. (1991) \u2018Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans\u2019, Pharmacol. Rev. 43, 527\u2013552.", "journal-title": "Pharmacol. Rev."}, {"key": "26_CR32", "first-page": "4", "volume": "4", "author": "TP Blackburn", "year": "1990", "unstructured": "Blackburn, T. P. and Kennett, G. A. (1990) \u2018Anxiolytic-like actions of BRL 46470 - a novel 5-HT3antagonist\u2019, J. Psychopharmacol. 4, 4.", "journal-title": "J. Psychopharmacol."}, {"key": "26_CR33", "doi-asserted-by": "publisher", "first-page": "227", "DOI": "10.1016/0165-1781(91)90013-F", "volume": "38", "author": "JP Seibyl", "year": "1991", "unstructured": "Seibyl, J. P., Krystal, J. H., Price, L. H., Woods, S. W., D\u2019Amico, C., Heninger, G. R., and Charney, D. S. (1991) \u2018Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to metachlorophenylpiperazine in healthy human subjects\u2019, Psychiatry Res. 38, 227\u2013236.", "journal-title": "Psychiatry Res"}, {"key": "26_CR34", "doi-asserted-by": "publisher", "first-page": "418", "DOI": "10.1016/0006-3223(91)90264-M", "volume": "29", "author": "TA Pigott", "year": "1991", "unstructured": "Pigott, T. A., Zohar, J., Hill, J. L., Bernstein, S. E., Grover, G. N., Zohar- Kadouch, R. C., and Murphy, D. L. (1991) \u2018Metergoline blocks the behavioral and neuroendocrine effects of orally administered mchlorophenylpiperazine in patients with obsessive-compulsive disorder\u2019, Biological Psychiatry 29, 418\u2013426.", "journal-title": "Biological Psychiatry"}, {"key": "26_CR35", "unstructured": "Pigott, T. A., Hill, J. L., Grady, T. A., L\u2019Heureux, F., Bernstein, S. E., Rubenstein, C. S., and Murphy, D. L. (1993) \u2018A comparison of the behavioral effects of oral versus intravenous m-CPP administration in OCD patients and a study of the effect of metergoline prior to IV m-CPP\u2019, Biol. Psychiatry, in press.", "DOI": "10.1016/0006-3223(93)90272-F", "doi-asserted-by": "crossref"}, {"key": "26_CR36", "doi-asserted-by": "publisher", "first-page": "167", "DOI": "10.1001/archpsyc.1988.01800260081011", "volume": "45", "author": "J Zohar", "year": "1988", "unstructured": "Zohar, J., Insel, T. R., Zohar-Kadouch, R. C., Hill, J. L., and Murphy, D. L. (1988) \u2018Serotonergic responsivity in obsessive-compulsive disorder: Effects of chronic clomipramine treatment\u2019, Arch. Gen. Psychiatry 45, 167\u2013172.", "journal-title": "Arch. Gen. Psychiatry"}, {"key": "26_CR37", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/0165-1781(91)90113-4", "volume": "36", "author": "E Hollander", "year": "1991", "unstructured": "Hollander, E., DeCaria, C., Gully, R., Nitescu, A., Suckow, R. F., Gorman, J. M., Klein, D. F., and Liebowitz, M. R. (1991) \u2018Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to metachloro-phenylpiperazine in obsessive-compulsive disorder\u2019, Psychiatry Res. 36, 1\u201317.", "journal-title": "Psychiatry Res"}, {"key": "26_CR38", "doi-asserted-by": "publisher", "first-page": "339", "DOI": "10.1007/BF02244603", "volume": "100", "author": "RS Kahn", "year": "1990", "unstructured": "Kahn, R. S., Wetzler, S., Asnis, G. M., Kling, M. A., Suckow, R. F., and vanPraag, H. M. (1990) \u2018Effects of m-chlorophenylpiperazine in normal subjects: A dose-response study\u2019, Psychopharmacology 100, 339\u2013344.", "journal-title": "Psychopharmacology"}, {"key": "26_CR39", "doi-asserted-by": "publisher", "first-page": "1139", "DOI": "10.1016/0006-3223(91)90184-N", "volume": "30", "author": "RS Kahn", "year": "1991", "unstructured": "Kahn, R. S. and Wetzler, S. (1991) \u2018m-Chlorophenylpiperazine as a probe of serotonin function\u2019, Biol. Psychiatry 30, 1139\u20131166.", "journal-title": "Biol. Psychiatry"}, {"key": "26_CR40", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1007/BF00444705", "volume": "98", "author": "DL Murphy", "year": "1989", "unstructured": "Murphy, D. L., Mueller, E. A., Hill, J. L., Tolliver, T. J., and Jacobsen, F. M. (1989) \u2018Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers\u2019, Psychopharmacology 98, 275\u2013282.", "journal-title": "Psychopharmacology"}], "container-title": ["Medical Science Symposia Series", "Serotonin"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-94-011-1920-7_26", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 16]], "date-time": "2019-05-16T16:45:32Z", "timestamp": 1558025132000}, "score": 31.696451, "issued": {"date-parts": [[1993]]}, "ISBN": ["9789401048491", "9789401119207"], "references-count": 40, "URL": "http://dx.doi.org/10.1007/978-94-011-1920-7_26", "relation": {"cites": []}, "ISSN": ["0928-9550"], "issn-type": [{"value": "0928-9550", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T10:55:39Z", "timestamp": 1574160939105}, "reference-count": 31, "publisher": "Elsevier BV", "issue": "1-2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1985, 12, 1]], "date-time": "1985-12-01T00:00:00Z", "timestamp": 502243200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Brain Research"], "published-print": {"date-parts": [[1985, 12]]}, "DOI": "10.1016/0006-8993(85)90956-4", "type": "journal-article", "created": {"date-parts": [[2003, 4, 24]], "date-time": "2003-04-24T20:22:24Z", "timestamp": 1051215744000}, "page": "129-136", "source": "Crossref", "is-referenced-by-count": 63, "title": ["Autoradiographic identification and topographical analyses of high affinity serotonin receptor subtypes as a target for the novel putative anxiolytic TVX Q 7821"], "prefix": "10.1016", "volume": "358", "author": [{"given": "T.", "family": "Glaser", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Rath", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Traber", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Zilles", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Schleicher", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Brain Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0006899385909564?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0006899385909564?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 23]], "date-time": "2019-03-23T13:57:33Z", "timestamp": 1553349453000}, "score": 30.280859, "issued": {"date-parts": [[1985, 12]]}, "references-count": 31, "journal-issue": {"published-print": {"date-parts": [[1985, 12]]}, "issue": "1-2"}, "alternative-id": ["0006899385909564"], "URL": "http://dx.doi.org/10.1016/0006-8993(85)90956-4", "ISSN": ["0006-8993"], "issn-type": [{"value": "0006-8993", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T21:46:31Z", "timestamp": 1575236791515}, "reference-count": 0, "publisher": "Worldwide Protein Data Bank", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.2210/pdb6c38/pdb", "type": "component", "created": {"date-parts": [[2018, 1, 30]], "date-time": "2018-01-30T19:04:08Z", "timestamp": 1517339048000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Structure of the D2 Dopamine Receptor Bound to the Atypical Antipsychotic Drug Risperidone"], "prefix": "10.2210", "author": [{"given": "S.", "family": "Wang", "sequence": "first", "affiliation": []}, {"given": "T.", "family": "Che", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Levit", "sequence": "additional", "affiliation": []}, {"given": "B.K.", "family": "Shoichet", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Wacker", "sequence": "additional", "affiliation": []}, {"given": "B.L.", "family": "Roth", "sequence": "additional", "affiliation": []}], "member": "7763", "published-online": {"date-parts": [[2018, 1, 31]]}, "deposited": {"date-parts": [[2019, 9, 30]], "date-time": "2019-09-30T15:28:29Z", "timestamp": 1569857309000}, "score": 30.198526, "issued": {"date-parts": [[2018, 1, 31]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2210/pdb6c38/pdb"}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T04:58:46Z", "timestamp": 1575262726138}, "reference-count": 0, "publisher": "Worldwide Protein Data Bank", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.2210/pdb6cm4/pdb", "type": "component", "created": {"date-parts": [[2018, 3, 13]], "date-time": "2018-03-13T18:04:13Z", "timestamp": 1520964253000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Structure of the D2 Dopamine Receptor Bound to the Atypical Antipsychotic Drug Risperidone"], "prefix": "10.2210", "author": [{"given": "S.", "family": "Wang", "sequence": "first", "affiliation": []}, {"given": "T.", "family": "Che", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Levit", "sequence": "additional", "affiliation": []}, {"given": "B.K.", "family": "Shoichet", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Wacker", "sequence": "additional", "affiliation": []}, {"given": "B.L.", "family": "Roth", "sequence": "additional", "affiliation": []}], "member": "7763", "published-online": {"date-parts": [[2018, 3, 14]]}, "deposited": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T20:16:22Z", "timestamp": 1574799382000}, "score": 30.198526, "issued": {"date-parts": [[2018, 3, 14]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2210/pdb6cm4/pdb"}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T16:51:32Z", "timestamp": 1575132692789}, "reference-count": 49, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2005, 3, 15]], "date-time": "2005-03-15T00:00:00Z", "timestamp": 1110844800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Psychopharmacology"], "published-print": {"date-parts": [[2005, 7]]}, "DOI": "10.1007/s00213-005-2172-z", "type": "journal-article", "created": {"date-parts": [[2005, 3, 14]], "date-time": "2005-03-14T18:19:21Z", "timestamp": 1110824361000}, "page": "377-384", "source": "Crossref", "is-referenced-by-count": 7, "title": ["A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian)"], "prefix": "10.1007", "volume": "180", "author": [{"given": "Y.", "family": "Hod\u00e9", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Reimold", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Demazi\u00e8res", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Reischl", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Bayle", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Nuss", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Hameg", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Dib", "sequence": "additional", "affiliation": []}, {"given": "J. P.", "family": "Macher", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2005, 3, 15]]}, "reference": [{"issue": "5", "key": "2172_CR1", "doi-asserted-by": "crossref", "first-page": "474", "DOI": "10.1001/archneur.1993.00540050026010", "volume": "50", "author": "A Antonini", "year": "1993", "unstructured": "Antonini A, Leenders K, Reist H, Thomann R, Beer H, Locher J (1993) Effects of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride. Arch Neurol 50(5):474\u2013480", "journal-title": "Arch Neurol"}, {"key": "2172_CR2", "doi-asserted-by": "crossref", "first-page": "672", "DOI": "10.1192/bjp.154.5.672", "volume": "154", "author": "TRE Barnes", "year": "1989", "unstructured": "Barnes TRE (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154:672\u2013676", "journal-title": "Br J Psychiatry"}, {"issue": "suppl 38", "key": "2172_CR3", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1192/S0007125000298085", "volume": "194", "author": "V Bigliani", "year": "1999", "unstructured": "Bigliani V, Pilowski LS (1999) In vivo neuropharmacology of schizophrenia. Br J Psychiatry 194(suppl 38):23\u201333", "journal-title": "Br J Psychiatry"}, {"key": "2172_CR4", "doi-asserted-by": "crossref", "first-page": "87", "DOI": "10.1016/S0166-4328(01)00238-8", "volume": "124", "author": "M Bourin", "year": "2001", "unstructured": "Bourin M, Nic Dhonnchadha BA, Colombel MC, Dib M, Hasco\u00ebt M (2001) Cyamemazine as an anxiolytic drug on the elevated plus maze and light/dark paradigm in mice. Behav Brain Res 124:87\u201395", "journal-title": "Behav Brain Res"}, {"key": "2172_CR5", "unstructured": "Bourin M, Dailly E, Hameg A, Dib M, Garay RP, Hasco\u00ebt M (2004a) A study of the antipsychotic action of cyamemazine in mouse behavioral models. Collegium Internationale Neuro-Psychopharmacologicum/XXIVth CINP Congress. Paris, June 20\u201324, 2004"}, {"issue": "3", "key": "2172_CR6", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1111/j.1527-3458.2004.tb00023.x", "volume": "10", "author": "M Bourin", "year": "2004", "unstructured": "Bourin M, Dailly E, Hascoet M (2004b). Preclinical and clinical pharmacology of cyamemazine: anxiolytic effects and prevention of alcohol and benzodiazepine withdrawal syndrome. CNS Drug Rev 10(3):219\u2013229", "journal-title": "CNS Drug Rev"}, {"issue": "2", "key": "2172_CR7", "first-page": "129", "volume": "28", "author": "A Brunot", "year": "2002", "unstructured": "Brunot A, Lachaux B, Sontag H, Casadebaig F, Philippe A, Rouillon F et al (2002) Pharmaco-epidemiological study on antipsychotic drug prescription in French psychiatry: patient characteristics, antipsychotic treatment, and care management for schizophrenia. Encephale 28(2):129\u2013138", "journal-title": "Encephale"}, {"key": "2172_CR8", "first-page": "367", "volume": "47", "author": "D Daniel", "year": "1995", "unstructured": "Daniel D (1995) Metabolism of psychotropic drugs: pharmacological and clinical relevance. Pol J Pharmacol 47:367\u2013379", "journal-title": "Pol J Pharmacol"}, {"key": "2172_CR9", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1016/0883-2889(86)90100-0", "volume": "37", "author": "RF Dannals", "year": "1986", "unstructured": "Dannals RF, Ravert HT, Wilson AA, Wagner HN (1986) An improved synthesis of (3-N-[11C]methyl)spiperone. Appl Radiat Isotopes 37:433\u2013434", "journal-title": "Appl Radiat Isotopes"}, {"key": "2172_CR10", "doi-asserted-by": "crossref", "first-page": "931", "DOI": "10.1002/jlcr.2580240808", "volume": "24", "author": "E Ehrin", "year": "1987", "unstructured": "Ehrin E, Gawell L, H\u00f6gberg T, de Paulis S, Str\u00f6m P (1987). Synthesis of [methoxy-3H]- and [methoxy-11C]-labelled raclopride. Specific dopamine-D2 receptor ligands. J Labelled Compd Radiopharm 24:931\u2013940", "journal-title": "J Labelled Compd Radiopharm"}, {"key": "2172_CR11", "doi-asserted-by": "crossref", "first-page": "696", "DOI": "10.1038/jcbfm.1989.98", "volume": "9", "author": "L Farde", "year": "1989", "unstructured": "Farde L, Eriksson L, Blomquist G, Halldin C (1989) Kinetic analysis of central [11C]-raclopride binding to D2-dopamine receptors studied by PET\u2014a comparison to the equilibrium analysis. J Cereb Blood Flow Metab 9:696\u2013708", "journal-title": "J Cereb Blood Flow Metab"}, {"key": "2172_CR12", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1001/archpsyc.1990.01810150013003", "volume": "47", "author": "L Farde", "year": "1990", "unstructured": "Farde L, Wiesel FA, Stone-Elander S, Halldin C, Nordstr\u00f6m AL, Hall H, Sedvall G (1990) D2 dopamine receptors in neuroleptic naive schizophrenic patients. Arch Gen Psychiatry 47:213\u2013219", "journal-title": "Arch Gen Psychiatry"}, {"key": "2172_CR13", "doi-asserted-by": "crossref", "first-page": "538", "DOI": "10.1001/archpsyc.1992.01820070032005", "volume": "49", "author": "L Farde", "year": "1992", "unstructured": "Farde L, Nordstrom AL, Wiesel FA, Pauli S, Halldin C, Sedvall G (1992) Positron emission tomography analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to extrapyramidal side effects. Arch Gen Psychiatry 49:538\u2013544", "journal-title": "Arch Gen Psychiatry"}, {"issue": "9(suppl B)", "key": "2172_CR14", "first-page": "67", "volume": "55", "author": "L Farde", "year": "1994", "unstructured": "Farde L, Nordstrom AL, Nyberg S, Halldin C, Sedvall G (1994) D1-, D2- and 5-HT2 receptor occupancy in clozapine treated patients. J Clin Psychiatry 55:9(suppl B):67\u201369", "journal-title": "J Clin Psychiatry"}, {"key": "2172_CR15", "doi-asserted-by": "crossref", "first-page": "80", "DOI": "10.1046/j.1365-2125.2000.00108.x", "volume": "49", "author": "A Fourrier", "year": "2000", "unstructured": "Fourrier A, Gasquet I, Allicar MP, Bouhassira M, L\u00e9pine JP, B\u00e9gaud B (2000) Patterns of neuroleptic drug prescription: a national cross-sectional survey of a random sample of French psychiatrists. J Clin Pharmacol 49:80\u201386", "journal-title": "J Clin Pharmacol"}, {"key": "2172_CR16", "first-page": "954", "volume": "8", "author": "C Gury", "year": "2000", "unstructured": "Gury C, Berchot F, Fabre C, Surugue J, Welcomme N (2000) Analysis of neuroleptics prescriptions in five specialized hospitals: comparison between hospital prescriptions and discharge prescriptions. Inf Psychiatr 8:954\u2013963", "journal-title": "Inf Psychiatr"}, {"key": "2172_CR17", "first-page": "comparative", "volume": "2002", "author": "Gury", "year": "2004", "unstructured": "Gury C, Simo E, Fabre C, Surugue J, Welcomme N (2004) Prescriptions of antipsychotic drugs in five specialized hospital centers in 2002: comparative analysis with 1998. Collegium Internationale Neuro-Psychopharmacologicum/XXIVth CINP Congress. Paris, June 20\u201324, 2004", "journal-title": "Prescriptions of antipsychotic drugs in five specialized hospital centers in"}, {"key": "2172_CR18", "author": "W Guy", "first-page": "218", "year": "1976", "unstructured": "Guy W (1976) Clinical Global Impression. ECDEU Assessment Manual for Psychopharmacology, ECDEU: National Institutes of Health, pp 218\u2013222", "volume-title": "Clinical Global Impression. ECDEU Assessment Nanual for Psychopharmacology"}, {"key": "2172_CR19", "first-page": "1275", "volume": "36", "author": "C Halldin", "year": "1995", "unstructured": "Halldin C, Farde L, Hogberg T, Mohell N, Hall H, Suhara T, Karlsson P, Nakashima Y, Swahn CG (1995) Carbon-11-FLB457: a radioligand for extrastriatal D2 dopamine receptors. J Nucl Med 36:1275\u20131281", "journal-title": "J Nucl Med"}, {"key": "2172_CR20", "first-page": "1", "volume": "7497", "author": "A Hameg", "year": "2003", "unstructured": "Hameg A, Bayle F, Nuss P, Dupuis P, Garay PR, Dib M (2003) Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine versus serotonin receptor subtypes. Biochem Pharmacol 7497:1\u20136", "journal-title": "Biochem Pharmacol"}, {"key": "2172_CR21", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1111/j.2044-8341.1959.tb00467.x", "volume": "32", "author": "M Hamilton", "year": "1959", "unstructured": "Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50\u201355", "journal-title": "Br J Med Psychol"}, {"issue": "2", "key": "2172_CR22", "doi-asserted-by": "crossref", "first-page": "116", "DOI": "10.1001/archpsyc.1994.03950020040004", "volume": "51", "author": "J Hietala", "year": "1994", "unstructured": "Hietala J, Syvalahti E, Vuorio K, Nagren K, Lehikoinen P, Ruotsalainen U, Rakkolainen V, Lehtinen V, Wagelius U (1994) Stratial D2 dopamine receptor characteristics in neuroleptic-naive scizophrenic patients studied with positron emission tomography. Arch Gen Psychiatry 51(2):116\u2013123", "journal-title": "Arch Gen Psychiatry"}, {"key": "2172_CR23", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1016/0278-5846(93)90075-4", "volume": "17", "author": "M Iyo", "year": "1993", "unstructured": "Iyo M, Yamasaki T (1993) The detection of age-related decrease of dopamine D1, D2 and serotonin 5-HT2 receptors in living human brain. Prog Neuro-psychopharmacol Biol Psychiatry 17:415\u2013421", "journal-title": "Prog Neuro-psychopharmacol Biol Psychiatry"}, {"key": "2172_CR24", "doi-asserted-by": "crossref", "first-page": "562", "DOI": "10.1016/S0893-133X(96)00100-5", "volume": "15", "author": "S Kapur", "year": "1996", "unstructured": "Kapur S, Zipursky R, Jones C, Remington G, Wilson A, DaSilva J, Houle S (1996) The D2 receptor occupancy profile of loxapine determined using PET. Neuropsychopharmacology 15:562\u2013566", "journal-title": "Neuropsychopharmacology"}, {"key": "2172_CR25", "doi-asserted-by": "crossref", "first-page": "148", "DOI": "10.1007/s002130050277", "volume": "131", "author": "S Kapur", "year": "1997", "unstructured": "Kapur S, Zipursky R, Roy P, Jones C, Remington G, Reed K, Houle S (1997) The relationship between D2 receptor occupancy and plasma levels on low dose oral haloperidol: a PET study. Psychopharmacology 131:148\u2013152", "journal-title": "Psychopharmacology"}, {"issue": "7", "key": "2172_CR26", "doi-asserted-by": "crossref", "first-page": "921", "DOI": "10.1176/ajp.155.7.921", "volume": "155", "author": "S Kapur", "year": "1998", "unstructured": "Kapur S, Zipursky RB, Remington G, Jones C, Da Silva J, Wilson AA, Houle S (1998) 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Am J Psychiatry 155(7):921\u2013928", "journal-title": "Am J Psychiatry"}, {"issue": "2", "key": "2172_CR27", "first-page": "286", "volume": "156", "author": "S Kapur", "year": "1999", "unstructured": "Kapur S, Zipursky R, Remington G (1999) Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am J Psychiatry 156(2):286\u2013293", "journal-title": "Am J Psychiatry"}, {"key": "2172_CR28", "doi-asserted-by": "crossref", "first-page": "514", "DOI": "10.1176/appi.ajp.157.4.514", "volume": "157", "author": "S Kapur", "year": "2000", "unstructured": "Kapur S, Zipursky R, Jones C, Remington G, Houle S (2000) Relationship between dopamine D2 occupancy, clinical response and side effects: a double blind PET study of first-episode schizophrenia. Am J Psychiatry 157:514\u2013520", "journal-title": "Am J Psychiatry"}, {"key": "2172_CR29", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1093/schbul/13.2.261", "volume": "13", "author": "SR Kay", "year": "1987", "unstructured": "Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276", "journal-title": "Schizophr Bull"}, {"key": "2172_CR30", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1006/nimg.1996.0066", "volume": "4", "author": "AA Lammerstma", "year": "1996", "unstructured": "Lammerstma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. NeuroImage 4:153\u2013158", "journal-title": "NeuroImage"}, {"key": "2172_CR31", "doi-asserted-by": "crossref", "first-page": "834", "DOI": "10.1097/00004647-199609000-00008", "volume": "16", "author": "J Logan", "year": "1996", "unstructured": "Logan J, Fowler JS, Wolf AP, Fowler JS, Brodie JD, Angrist B, Volkow ND, Gatley SJ (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834\u2013840", "journal-title": "J Cereb Blood Flow Metab"}, {"key": "2172_CR32", "doi-asserted-by": "crossref", "first-page": "346", "DOI": "10.1192/bjp.158.3.346", "volume": "158", "author": "JL Martinot", "year": "1991", "unstructured": "Martinot JL, Paill\u00e8re-Martinot ML, Lo\u2019ch C, Hardy P, Poirier MF, Mazoyer B, Beaufils B, Maziere B, Allilaire JF, Syrota A (1991) The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br bromolisuride. Br J Psychiatry 158:346\u2013350", "journal-title": "Br J Psychiatry"}, {"key": "2172_CR33", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1016/0006-3223(93)90288-O", "volume": "33", "author": "AL Nordstr\u00f6m", "year": "1993", "unstructured": "Nordstr\u00f6m AL, Farde L, Wiesel FA, Forslund K, Pauli S, Halldin G, Uppfeldt G (1993). Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects\u2014a double blind PET study of schizophrenic patients. Biol Psychiatry 33:227\u2013235", "journal-title": "Biol Psychiatry"}, {"issue": "10", "key": "2172_CR34", "doi-asserted-by": "crossref", "first-page": "1444", "DOI": "10.1176/ajp.152.10.1444", "volume": "152", "author": "AL Nordstr\u00f6m", "year": "1995", "unstructured": "Nordstr\u00f6m AL, Farde L, Nyberg S, Karlsson P, Halldin C, Sedvall G (1995) D1, D2 and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am J Psychiatry 152 (10):1444\u20131449", "journal-title": "Am J Psychiatry"}, {"key": "2172_CR35", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1007/BF02251280", "volume": "110", "author": "S Nyberg", "year": "1993", "unstructured": "Nyberg S, Farde L, Eriksson L, Halldin C, Eriksson B (1993) 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone. Psychopharmacology 110:265\u2013272", "journal-title": "Psychopharmacology"}, {"issue": "suppl 29", "key": "2172_CR36", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1192/S0007125000298309", "volume": "168", "author": "S Nyberg", "year": "1996", "unstructured": "Nyberg S, Nakashima Y, Nordstr\u00f6m AL, Halldin C, Farde L (1996) Positron emission tomography of in-vivo binding characteristics of atypical antipsychotic drugs. Review of D2 and 5-HT2 receptor occupancy studies and clinical response. Br J Psychiatry 168(suppl 29):40\u201344", "journal-title": "Br J Psychiatry"}, {"issue": "suppl 3", "key": "2172_CR37", "doi-asserted-by": "crossref", "first-page": "S15", "DOI": "10.1097/00004850-199803003-00003", "volume": "13", "author": "S Nyberg", "year": "1998", "unstructured": "Nyberg S, Nilsson U, Okubo Y, Halldin C, Farde L (1998) Implication of brain imaging for the management of schizophrenia. Int Clin Psychopharmacol 13(suppl 3):S15\u2013S20", "journal-title": "Int Clin Psychopharmacol"}, {"issue": "6", "key": "2172_CR38", "doi-asserted-by": "crossref", "first-page": "869", "DOI": "10.1176/ajp.156.6.869", "volume": "156", "author": "S Nyberg", "year": "1999", "unstructured": "Nyberg S, Eriksson L, Oxenstierna G, Halldin C, Farde L (1999) Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients. Am J Psychiatry 156(6):869\u2013875", "journal-title": "Am J Psychiatry"}, {"issue": "25", "key": "2172_CR39", "doi-asserted-by": "crossref", "first-page": "2455", "DOI": "10.1016/S0024-3205(00)80005-3", "volume": "66", "author": "Y Okubo", "year": "2000", "unstructured": "Okubo Y, Sahara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O, Someya Y, Sassa T, Sudo Y, Matsushima E, Iyo M, Tateno Y, Toru M (2000) Serotonin 5-HT2 receptors in schizophrenic patients studied by positron emission tomography. Life Sci 66(25):2455\u20132464", "journal-title": "Life Sci"}, {"key": "2172_CR40", "first-page": "967", "volume": "10", "author": "F Radat", "year": "1995", "unstructured": "Radat F (1995) Cyamemazine:traitement symptomatique desdimensions anxieuses, impulsives et agressives. Inf Psychiatr 10:967\u2013968", "journal-title": "Inf Psychiatr"}, {"issue": "4", "key": "2172_CR41", "doi-asserted-by": "crossref", "first-page": "564", "DOI": "10.1007/s00259-003-1389-5", "volume": "31", "author": "M Reimold", "year": "2004", "unstructured": "Reimold M, Mueller-Schauenburg W, Becker GA, Reischl G, Dohmen BM, Bares R (2004) Non-invasive assessment of distribution volume ratios and binding potential: tissue heterogeneity and interindividually averaged time\u2013activity curves. Eur J Nucl Med Mol Imaging 31(4):564\u2013577", "journal-title": "Eur J Nucl Med Mol Imaging"}, {"issue": "suppl 10", "key": "2172_CR42", "first-page": "5", "volume": "60", "author": "E Richelson", "year": "1999", "unstructured": "Richelson E (1999) Receptor pharmacology of neuroleptics: relation to clinical effects. J Clin Psychiatry 60(suppl 10):5\u201314", "journal-title": "J Clin Psychiatry"}, {"issue": "1", "key": "2172_CR43", "first-page": "22", "volume": "32", "author": "G Sedvall", "year": "1995", "unstructured": "Sedvall G, Pauli S, Farde L, Karlsson P, Nyberg S, Nordstr\u00f6m AL (1995). Recent developments in PET scan imaging of neuroreceptors in schizophrenia. Isr J Psychiatry Relat Sci 32(1):22\u201329", "journal-title": "Isr J Psychiatry Relat Sci"}, {"key": "2172_CR44", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1111/j.1600-0447.1970.tb02066.x", "volume": "212", "author": "GM Simpson", "year": "1970", "unstructured": "Simpson GM, Angus JWS (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212:11\u201319", "journal-title": "Acta Psychiatr Scand"}, {"key": "2172_CR45", "doi-asserted-by": "crossref", "first-page": "505", "DOI": "10.1176/ajp.155.4.505", "volume": "155", "author": "C Trichard", "year": "1998", "unstructured": "Trichard C, Paill\u00e8re-Martinot ML, Attar-Levy D, Recassens C, Monnet F, Martinot JL (1998) Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpiride in schizophrenic patients. Am J Psychiatry 155:505\u2013508", "journal-title": "Am J Psychiatry"}, {"key": "2172_CR46", "doi-asserted-by": "crossref", "first-page": "240", "DOI": "10.1097/00004647-200202000-00012", "volume": "22", "author": "J Varga", "year": "2002", "unstructured": "Varga J, Szabo Z (2002) Modified regression model for the Logan plot. J Cereb Blood Flow Metab 22:240\u2013244", "journal-title": "J Cereb Blood Flow Metab"}, {"key": "2172_CR47", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1016/0925-4927(96)02809-0", "volume": "67", "author": "ND Volkow", "year": "1996", "unstructured": "Volkow ND, Wang GJ, Fowler JS, Logan J et al (1996) Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol. Psychiatry Res 67:11\u201316", "journal-title": "Psychiatry Res"}, {"issue": "14", "key": "2172_CR48", "first-page": "249", "volume": "56", "author": "GJ Wang", "year": "1995", "unstructured": "Wang GJ, Volkow ND, Logan J, Fowler JS et al (1995) Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects. Life Sci 56(14):249\u2013253", "journal-title": "Life Sci"}, {"issue": "8", "key": "2172_CR49", "doi-asserted-by": "crossref", "first-page": "1496", "DOI": "10.1176/appi.ajp.161.8.1496", "volume": "161", "author": "YK Yang", "year": "2004", "unstructured": "Yang YK, Yu L, Yeh TL, Chiu NT, Chen PS, Lee IH (2004) Associated alterations of stratial dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study. Am J Psychiatry 161(8):1496\u20131498", "journal-title": "Am J Psychiatry"}], "container-title": ["Psychopharmacology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00213-005-2172-z.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00213-005-2172-z/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00213-005-2172-z", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 23]], "date-time": "2019-05-23T16:31:14Z", "timestamp": 1558629074000}, "score": 29.934792, "issued": {"date-parts": [[2005, 3, 15]]}, "references-count": 49, "journal-issue": {"published-print": {"date-parts": [[2005, 7]]}, "issue": "2"}, "alternative-id": ["2172"], "URL": "http://dx.doi.org/10.1007/s00213-005-2172-z", "relation": {"cites": []}, "ISSN": ["0033-3158", "1432-2072"], "issn-type": [{"value": "0033-3158", "type": "print"}, {"value": "1432-2072", "type": "electronic"}], "subject": ["Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T11:14:24Z", "timestamp": 1574162064813}, "reference-count": 29, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 10835, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Dev. Res."], "published-print": {"date-parts": [[1986, 1]]}, "DOI": "10.1002/ddr.430070104", "type": "journal-article", "created": {"date-parts": [[2005, 1, 1]], "date-time": "2005-01-01T02:55:35Z", "timestamp": 1104548135000}, "page": "35-47", "source": "Crossref", "is-referenced-by-count": 20, "title": ["The neuropharmacological profile of tefludazine, a potential antipsychotic drug with dopamine and serotonin receptor antagonistic effects"], "prefix": "10.1002", "volume": "7", "author": [{"given": "O.", "family": "Svendsen", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Arnt", "sequence": "additional", "affiliation": []}, {"given": "V.", "family": "Boeck", "sequence": "additional", "affiliation": []}, {"given": "K. P.", "family": "B\u00f8ges\u00f8", "sequence": "additional", "affiliation": []}, {"given": "A. V.", "family": "Christensen", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Hyttel", "sequence": "additional", "affiliation": []}, {"given": "J.-J.", "family": "Larsen", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2004, 10, 5]]}, "reference": [{"key": "10.1002/ddr.430070104-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "321", "DOI": "10.1111/j.1600-0773.1982.tb01032.x", "article-title": "Pharmacological specificity of conditioned avoidance response inhibition in rats: Inhibition by neuroleptics and correlation to dopamine receptor blockade", "volume": "51", "author": "Arnt", "year": "1982", "journal-title": "Acta Pharmacol. Toxicol. (Copenh.)"}, {"key": "10.1002/ddr.430070104-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1016/0014-2999(83)90212-1", "article-title": "Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into nucleus accumbens. Specificity and comparison with other models", "volume": "90", "author": "Arnt", "year": "1983", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1002/ddr.430070104-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1016/0014-2999(81)90608-7", "article-title": "Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics", "volume": "69", "author": "Arnt", "year": "1981", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1002/ddr.430070104-BIB4|cit4", "first-page": "1331", "article-title": "Differential reversal by scopolamine of effects of neuroleptics in rats. Relevance for evaluation of therapeutic and extrapyramidal side-effect potential", "volume": "20", "author": "Arnt", "year": "1981", "journal-title": "Neuropharmacology"}, {"key": "10.1002/ddr.430070104-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1111/j.1600-0773.1984.tb01996.x", "article-title": "The catalopram/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters", "volume": "55", "author": "Arnt", "year": "1984", "journal-title": "Acta Pharamacol. Toxicol. (Copenh.)"}, {"key": "10.1002/ddr.430070104-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1007/BF00426037", "article-title": "Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy", "volume": "62", "author": "Balsara", "year": "1979", "journal-title": "Psychopharmacology (Berlin)"}, {"key": "10.1002/ddr.430070104-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "935", "DOI": "10.1021/jm00361a002", "article-title": "Neuroleptic activity and dopamine-uptake inhibition of 1-piperazino-3-phenylindanes", "volume": "26", "author": "B\u00f8ges\u00f8", "year": "1983", "journal-title": "J. Med. Chem."}, {"key": "10.1002/ddr.430070104-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1007/BF00495549", "article-title": "A study of the sites of interaction between dopamine and 5-hydroxytrypt-amine for the production of fluphenazine-induced catalepsia", "volume": "304", "author": "Carter", "year": "1978", "journal-title": "Arch. Pharmacol."}, {"key": "10.1002/ddr.430070104-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "1490", "DOI": "10.1176/ajp.123.12.1490", "article-title": "Drug-induced extrapyramidal symptoms and their relations to clinical efficacy", "volume": "123", "author": "Chien", "year": "1967", "journal-title": "Am. J. Psychiatry"}, {"key": "10.1002/ddr.430070104-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1007/BF00426314", "article-title": "Inhibition of conditioned avoidance response by neuroleptics upon repeated administration", "volume": "51", "author": "Danneskiold-Sams\u00f8e", "year": "1974", "journal-title": "Psychopharmacology (Berlin)"}, {"key": "10.1002/ddr.430070104-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1159/000136458", "article-title": "Role of 5-HT in the action of some drugs affecting extrapyramidal system", "volume": "10", "author": "Gumulka", "year": "1973", "journal-title": "Pharmacology"}, {"key": "10.1002/ddr.430070104-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1016/0364-7722(78)90090-5", "article-title": "A comparison of the effect of neuroleptic drugs on the binding of 3H-haloperidol and 3H-cis(Z)-flupentixol and on adenylate cyclase activity in rat striatal tissue in vitro", "volume": "2", "author": "Hyttel", "year": "1978", "journal-title": "Prog. Neuropsychopharmacol. Biol. Psychiatry"}, {"key": "10.1002/ddr.430070104-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "563", "DOI": "10.1016/0024-3205(81)90150-8", "article-title": "Similarities between the binding of 3H-piflutixol and 3H-flupentixol to rat striatal dopamine receptors in vitro", "volume": "28", "author": "Hyttel", "year": "1981", "journal-title": "Life Sci."}, {"key": "10.1002/ddr.430070104-BIB14|cit14", "author": "Hyttel", "first-page": "147", "year": "1982", "volume-title": "Advances in Dopamine Research", "DOI": "10.1016/B978-0-08-027391-4.50017-4", "doi-asserted-by": "crossref"}, {"key": "10.1002/ddr.430070104-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1038/272168a0", "article-title": "Serotonergic component of neuroleptic receptors", "volume": "272", "author": "Leysen", "year": "1978", "journal-title": "Nature"}, {"key": "10.1002/ddr.430070104-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1016/0091-3057(75)90076-3", "article-title": "Antagonistic effect of cyproheptadine on neuroleptic-induced catalepsy", "volume": "3", "author": "Maj", "year": "1975", "journal-title": "Pharmacol. Biochem. Behav."}, {"key": "10.1002/ddr.430070104-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1016/0091-3057(76)90037-X", "article-title": "On the anticataleptic action of cyproheptadine", "volume": "5", "author": "Maj", "year": "1976", "journal-title": "Pharmacol. Biochem. Behav."}, {"key": "10.1002/ddr.430070104-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "353", "DOI": "10.1016/0165-6147(83)90437-6", "article-title": "Designing a non-neuroleptic antischizophrenic drug: The noradrenergic strategy", "volume": "4", "author": "Mason", "year": "1983", "journal-title": "Trends Pharmacol. Sci."}, {"key": "10.1002/ddr.430070104-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "288", "DOI": "10.1097/00004714-198310000-00004", "article-title": "The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs", "volume": "3", "author": "McEvoy", "year": "1983", "journal-title": "J. Clin. Psychopharmacol."}, {"key": "10.1002/ddr.430070104-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "178", "DOI": "10.1007/BF00404008", "article-title": "Influence of antiparkinson drugs and amphetamine on some pharmacological effects of phenothiazine derivatives used as neuroleptics", "volume": "6", "author": "Morpurgo", "year": "1964", "journal-title": "Psychopharmacologia (Berlin)"}, {"key": "10.1002/ddr.430070104-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1007/BF01962247", "article-title": "The pharmacological and biochemical basis of neuroleptic treatment of schizophrenia", "volume": "4", "author": "Niemegeers", "year": "1982", "journal-title": "Pharmaceutisch Weekblad Sci. Ed."}, {"key": "10.1002/ddr.430070104-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "361", "DOI": "10.1007/BF00421901", "article-title": "Apomorphine provoked stereotypy in the dog", "volume": "26", "author": "Nymark", "year": "1972", "journal-title": "Psychopharmacology (Berl.)"}, {"key": "10.1002/ddr.430070104-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "488", "DOI": "10.1111/j.1600-0773.1972.tb03612.x", "article-title": "Antagonism of methylphenidate-induced stereotyped gnawing in mice", "volume": "31", "author": "Pedersen", "year": "1972", "journal-title": "Acta Pharmacol. Toxicol. (Copenh.)"}, {"key": "10.1002/ddr.430070104-BIB24|cit24", "first-page": "687", "article-title": "Multiple serotonin receptors: Differential binding of [3H]5-hydroxy-tryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol", "volume": "16", "author": "Peroutka", "year": "1979", "journal-title": "Mol. Pharmacol."}, {"key": "10.1002/ddr.430070104-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "1518", "DOI": "10.1176/ajp.137.12.1518", "article-title": "Relationship of neuroleptic drug effects at brain dopamine, serotonin, \u03b1-adrenergic and histamine receptors to clinical potency", "volume": "137", "author": "Peroutka", "year": "1980", "journal-title": "Am. J. Psychiatry"}, {"key": "10.1002/ddr.430070104-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "827", "DOI": "10.1126/science.7221567", "article-title": "Two distinct central serotonin receptors with different physiological functions", "volume": "212", "author": "Peroutka", "year": "1981", "journal-title": "Science"}, {"key": "10.1002/ddr.430070104-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1016/0014-2999(76)90119-9", "article-title": "Differential attenuation of some effects of haloperidol in rats given scopolamine", "volume": "39", "author": "Setler", "year": "1976", "journal-title": "Eur. J. Pharmacol."}, {"key": "10.1002/ddr.430070104-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "877", "DOI": "10.1001/archpsyc.1983.01790070067008", "article-title": "LSD psychosis or LSD-induced schizophrenia? A multi-method inquiry", "volume": "40", "author": "Vardy", "year": "1983", "journal-title": "Arch. Gen. Psychiatry"}, {"key": "10.1002/ddr.430070104-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1016/0014-2999(79)90110-9", "article-title": "Serotonin-dopamine interactions in the nigro-striatal system", "volume": "55", "author": "Waldmeier", "year": "1979", "journal-title": "Eur. J. Pharmacol."}], "container-title": ["Drug Development Research"], "language": "en", "link": [{"URL": "http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fddr.430070104", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fddr.430070104", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/ddr.430070104", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 9]], "date-time": "2019-01-09T13:45:00Z", "timestamp": 1547041500000}, "score": 29.494528, "subtitle": ["Tefludazine-Neuropharmacological Profile"], "issued": {"date-parts": [[1986, 1]]}, "references-count": 29, "journal-issue": {"published-print": {"date-parts": [[1986, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1002/ddr.430070104", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0272-4391"], "issn-type": [{"value": "0272-4391", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T21:16:54Z", "timestamp": 1575407814862}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "10", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1998, 5, 15]]}, "DOI": "10.1093/ajhp/55.10.1003", "type": "journal-article", "created": {"date-parts": [[2019, 2, 23]], "date-time": "2019-02-23T03:45:39Z", "timestamp": 1550893539000}, "page": "1003-1016", "source": "Crossref", "is-referenced-by-count": 19, "title": ["Olanzapine: a serotonin-dopamine-receptor antagonist for antipsychotic therapy"], "prefix": "10.1093", "volume": "55", "author": [{"given": "Kristine A.", "family": "Bever", "sequence": "first", "affiliation": [{"name": "College of Pharmacy and Department of Psychiatry, College of Medicine"}]}, {"given": "Paul J.", "family": "Perry", "sequence": "additional", "affiliation": [{"name": "College of Pharmacy, and Professor of Psychiatry, College of Medicine, University of Iowa, Iowa City"}]}], "member": "286", "container-title": ["American Journal of Health-System Pharmacy"], "language": "en", "link": [{"URL": "http://academic.oup.com/ajhp/article-pdf/55/10/1003/28403083/ajhp1003.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 14]], "date-time": "2019-04-14T11:19:29Z", "timestamp": 1555240769000}, "score": 29.24769, "issued": {"date-parts": [[1998, 5, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1998, 5, 15]]}, "issue": "10"}, "URL": "http://dx.doi.org/10.1093/ajhp/55.10.1003", "ISSN": ["1079-2082", "1535-2900"], "issn-type": [{"value": "1079-2082", "type": "print"}, {"value": "1535-2900", "type": "electronic"}], "subject": ["Health Policy", "Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T19:45:26Z", "timestamp": 1574106326754}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1995, 2, 1]], "date-time": "1995-02-01T00:00:00Z", "timestamp": 791596800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1995, 2]]}, "DOI": "10.1016/0920-9964(94)00043-8", "type": "journal-article", "created": {"date-parts": [[2002, 10, 31]], "date-time": "2002-10-31T21:12:04Z", "timestamp": 1036098724000}, "page": "187-202", "source": "Crossref", "is-referenced-by-count": 108, "title": ["Serotonin, schizophrenia and antipsychotic drug action"], "prefix": "10.1016", "volume": "14", "author": [{"given": "A", "family": "Breier", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Schizophrenia Research"], "link": [{"URL": "https://api.elsevier.com/content/article/PII:0920-9964(94)00043-8?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0920-9964(94)00043-8?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 17]], "date-time": "2019-04-17T03:56:32Z", "timestamp": 1555473392000}, "score": 28.994793, "issued": {"date-parts": [[1995, 2]]}, "references-count": 0, "journal-issue": {"issue": "3"}, "alternative-id": ["0920-9964(94)00043-8"], "URL": "http://dx.doi.org/10.1016/0920-9964(94)00043-8", "ISSN": ["0920-9964"], "issn-type": [{"value": "0920-9964", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T14:58:18Z", "timestamp": 1574175498440}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CN"], "published-print": {"date-parts": [[2006, 1, 1]]}, "DOI": "10.2174/157015906775203020", "type": "journal-article", "created": {"date-parts": [[2005, 12, 28]], "date-time": "2005-12-28T21:03:11Z", "timestamp": 1135803791000}, "page": "59-68", "source": "Crossref", "is-referenced-by-count": 24, "title": ["Modulation of Midbrain Dopamine Neurotransmission by Serotonin, a Versatile Interaction Between Neurotransmitters and Significance for Antipsychotic Drug Action"], "prefix": "10.2174", "volume": "4", "author": [{"given": "J.", "family": "Olijslagers", "sequence": "first", "affiliation": []}, {"given": "T.", "family": "Werkman", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "McCreary", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Kruse", "sequence": "additional", "affiliation": []}, {"given": "W.", "family": "Wadman", "sequence": "additional", "affiliation": []}], "member": "965", "container-title": ["Current Neuropharmacology"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/55221", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2015, 11, 23]], "date-time": "2015-11-23T08:53:40Z", "timestamp": 1448268820000}, "score": 28.732046, "issued": {"date-parts": [[2006, 1, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2006, 1, 1]]}, "issue": "1"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/157015906775203020", "ISSN": ["1570-159X"], "issn-type": [{"value": "1570-159X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T22:34:40Z", "timestamp": 1574548480680}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 10, 1]], "date-time": "2014-10-01T00:00:00Z", "timestamp": 1412121600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Neuropsychopharmacology"], "published-print": {"date-parts": [[2014, 10]]}, "DOI": "10.1016/s0924-977x(14)70981-2", "type": "journal-article", "created": {"date-parts": [[2014, 9, 25]], "date-time": "2014-09-25T23:42:53Z", "timestamp": 1411688573000}, "page": "S612-S613", "source": "Crossref", "is-referenced-by-count": 0, "title": ["P.4.d.002 D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive\u2013compulsive disorders"], "prefix": "10.1016", "volume": "24", "author": [{"given": "G.", "family": "Fond", "sequence": "first", "affiliation": []}, {"given": "D.", "family": "Ducasse", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Michel", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Loundou", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Boyer", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Neuropsychopharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0924977X14709812?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0924977X14709812?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 29]], "date-time": "2018-09-29T11:56:31Z", "timestamp": 1538222191000}, "score": 28.61946, "issued": {"date-parts": [[2014, 10]]}, "references-count": 0, "alternative-id": ["S0924977X14709812"], "URL": "http://dx.doi.org/10.1016/s0924-977x(14)70981-2", "ISSN": ["0924-977X"], "issn-type": [{"value": "0924-977X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T16:33:01Z", "timestamp": 1575304381495}, "reference-count": 0, "publisher": "Elsevier", "isbn-type": [{"value": "9780444532350", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2008]]}, "DOI": "10.1016/s0079-6123(08)00908-4", "type": "book-chapter", "created": {"date-parts": [[2008, 9, 3]], "date-time": "2008-09-03T08:20:09Z", "timestamp": 1220430009000}, "page": "155-175", "source": "Crossref", "is-referenced-by-count": 22, "title": ["Role of serotonin and dopamine receptor binding in antipsychotic efficacy"], "prefix": "10.1016", "author": [{"given": "N", "family": "RICHTAND", "sequence": "first", "affiliation": []}, {"given": "J", "family": "WELGE", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "LOGUE", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "KECKJR", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "STRAKOWSKI", "sequence": "additional", "affiliation": []}, {"given": "R", "family": "MCNAMARA", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Progress in Brain Research", "Serotonin&#x2013;Dopamine Interaction: Experimental Evidence and Therapeutic Relevance"], "deposited": {"date-parts": [[2018, 12, 26]], "date-time": "2018-12-26T05:22:35Z", "timestamp": 1545801755000}, "score": 28.538235, "issued": {"date-parts": [[2008]]}, "ISBN": ["9780444532350"], "references-count": 0, "URL": "http://dx.doi.org/10.1016/s0079-6123(08)00908-4", "ISSN": ["0079-6123"], "issn-type": [{"value": "0079-6123", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T17:05:55Z", "timestamp": 1574096755908}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2-3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 2, 1]], "date-time": "1996-02-01T00:00:00Z", "timestamp": 823132800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Schizophrenia Research"], "published-print": {"date-parts": [[1996, 2]]}, "DOI": "10.1016/0920-9964(96)85463-6", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T14:09:51Z", "timestamp": 1027606191000}, "page": "140", "source": "Crossref", "is-referenced-by-count": 0, "title": ["New dopamine- and serotonin receptor subtypes, targets for antipsychotics drugs in vivo?"], "prefix": "10.1016", "volume": "18", "author": [{"given": "J.E.", "family": "Leysen", "sequence": "first", "affiliation": []}, {"given": "W.", "family": "Gommeren", "sequence": "additional", "affiliation": []}, {"given": "P.M.F.", "family": "Janssen", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Schotte", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Schizophrenia Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0920996496854636?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0920996496854636?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 28]], "date-time": "2019-04-28T16:54:46Z", "timestamp": 1556470486000}, "score": 28.410519, "issued": {"date-parts": [[1996, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1996, 2]]}, "issue": "2-3"}, "alternative-id": ["0920996496854636"], "URL": "http://dx.doi.org/10.1016/0920-9964(96)85463-6", "ISSN": ["0920-9964"], "issn-type": [{"value": "0920-9964", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T17:00:55Z", "timestamp": 1574269255288}, "reference-count": 59, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2007, 1, 24]], "date-time": "2007-01-24T00:00:00Z", "timestamp": 1169596800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neuropsychopharmacol"], "published-print": {"date-parts": [[2007, 8]]}, "DOI": "10.1038/sj.npp.1301305", "type": "journal-article", "created": {"date-parts": [[2007, 1, 25]], "date-time": "2007-01-25T00:39:12Z", "timestamp": 1169685552000}, "page": "1715-1726", "source": "Crossref", "is-referenced-by-count": 63, "title": ["Dopamine and Serotonin Receptor Binding and Antipsychotic Efficacy"], "prefix": "10.1038", "volume": "32", "author": [{"given": "Neil M", "family": "Richtand", "sequence": "first", "affiliation": []}, {"given": "Jeffrey A", "family": "Welge", "sequence": "additional", "affiliation": []}, {"given": "Aaron D", "family": "Logue", "sequence": "additional", "affiliation": []}, {"given": "Paul E", "family": "Keck", "sequence": "additional", "affiliation": []}, {"given": "Stephen M", "family": "Strakowski", "sequence": "additional", "affiliation": []}, {"given": "Robert K", "family": "McNamara", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2007, 1, 24]]}, "reference": [{"key": "BF1301305_CR1", "doi-asserted-by": "publisher", "first-page": "242", "DOI": "10.1002/syn.20109", "volume": "55", "author": "KD Alex", "year": "2005", "unstructured": "Alex KD, Yavanian GJ, McFarlane HG, Pluto CP, Pehek EA (2005). Modulation of dopamine release by striatal 5-HT2C receptors. Synapse 55: 242\u2013251.", "journal-title": "Synapse"}, {"key": "BF1301305_CR2", "first-page": "138", "volume": "10", "author": "RJ Baldessarini", "year": "1993", "unstructured": "Baldessarini RJ, Cohen BM, Teicher MH (1993). Clinical dosing of neuroleptics. Psychopharmacol Ser 10: 138\u2013148.", "journal-title": "Psychopharmacol Ser"}, {"key": "BF1301305_CR3", "author": "JG Bernstein", "year": "1988", "unstructured": "Bernstein JG (1988). Handbook of Drug Therapy in Psychiatry. PSG Publishing Company, Inc.: Littleton, MA.", "volume-title": "Handbook of Drug Therapy in Psychiatry"}, {"key": "BF1301305_CR4", "doi-asserted-by": "publisher", "first-page": "307", "DOI": "10.1017/S003329170002729X", "volume": "24", "author": "P Bollini", "year": "1994", "unstructured": "Bollini P, Pampallona S, Orza MJ, Adams ME, Chalmers TC (1994). Antipsychotic drugs: is more worse? A meta-analysis of the published randomized control trials. Psychol Med 24: 307\u2013316.", "journal-title": "Psychol Med"}, {"key": "BF1301305_CR5", "doi-asserted-by": "publisher", "first-page": "783", "DOI": "10.1038/336783a0", "volume": "336", "author": "JR Bunzow", "year": "1988", "unstructured": "Bunzow JR, Van Tol HH, Grandy DK, Albert P, Salon J, Christie M et al (1988). Cloning and expression of a rat D2 dopamine receptor cDNA. Nature 336: 783\u2013787.", "journal-title": "Nature"}, {"issue": "Suppl 4", "key": "BF1301305_CR6", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1007/PL00014183", "volume": "249", "author": "A Carlsson", "year": "1999", "unstructured": "Carlsson A, Waters N, Carlsson ML (1999). Neurotransmitter interactions in schizophrenia-therapeutic implications. Eur Arch Psychiatry Clin Neurosci 249 (Suppl 4): 37\u201343.", "journal-title": "Eur Arch Psychiatry Clin Neurosci"}, {"key": "BF1301305_CR7", "doi-asserted-by": "publisher", "first-page": "481", "DOI": "10.1126/science.3854", "volume": "192", "author": "I Creese", "year": "1976", "unstructured": "Creese I, Burt DR, Snyder SH (1976). Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192: 481\u2013483.", "journal-title": "Science"}, {"key": "BF1301305_CR8", "doi-asserted-by": "publisher", "first-page": "3235", "DOI": "10.1523/JNEUROSCI.0112-04.2004", "volume": "24", "author": "P De Deurwaerdere", "year": "2004", "unstructured": "De Deurwaerdere P, Navailles S, Berg KA, Clarke WP, Spampinato U (2004). Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J Neurosci 24: 3235\u20133241.", "journal-title": "J Neurosci"}, {"key": "BF1301305_CR9", "doi-asserted-by": "publisher", "first-page": "1033", "DOI": "10.1046/j.1471-4159.1999.0731033.x", "volume": "73", "author": "P De Deurwaerdere", "year": "1999", "unstructured": "De Deurwaerdere P, Spampinato U (1999). Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation. J Neurochem 73: 1033\u20131042.", "journal-title": "J Neurochem"}, {"key": "BF1301305_CR10", "doi-asserted-by": "publisher", "first-page": "587", "DOI": "10.1016/S0306-4522(98)00655-1", "volume": "91", "author": "G Di Giovanni", "year": "1999", "unstructured": "Di Giovanni G, De Deurwaerdere P, Di Mascio M, Di Matteo V, Esposito E, Spampinato U (1999). Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience 91: 587\u2013597.", "journal-title": "Neuroscience"}, {"key": "BF1301305_CR11", "doi-asserted-by": "publisher", "first-page": "727", "DOI": "10.1016/S0091-3057(01)00705-5", "volume": "71", "author": "V Di Matteo", "year": "2002", "unstructured": "Di Matteo V, Cacchio M, Di Giulio C, Esposito E (2002). Role of serotonin(2C) receptors in the control of brain dopaminergic function. Pharmacol Biochem Behav 71: 727\u2013734.", "journal-title": "Pharmacol Biochem Behav"}, {"key": "BF1301305_CR12", "doi-asserted-by": "publisher", "first-page": "1195", "DOI": "10.1016/S0028-3908(99)00047-7", "volume": "38", "author": "V Di Matteo", "year": "1999", "unstructured": "Di Matteo V, Di Giovanni G, Di Mascio M, Esposito E (1999). SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 38: 1195\u20131205.", "journal-title": "Neuropharmacology"}, {"key": "BF1301305_CR13", "doi-asserted-by": "publisher", "first-page": "233", "DOI": "10.1002/(SICI)1096-9861(19970728)384:2<233::AID-CNE5>3.0.CO;2-2", "volume": "384", "author": "K Eberle-Wang", "year": "1997", "unstructured": "Eberle-Wang K, Mikeladze Z, Uryu K, Chesselet MF (1997). Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats. J Comp Neurol 384: 233\u2013247.", "journal-title": "J Comp Neurol"}, {"key": "BF1301305_CR14", "doi-asserted-by": "publisher", "first-page": "133", "DOI": "10.1016/S0163-7258(99)00029-7", "volume": "84", "author": "G Emilien", "year": "1999", "unstructured": "Emilien G, Maloteaux JM, Geurts M, Hoogenberg K, Cragg S (1999). Dopamine receptors\u2014physiological understanding to therapeutic intervention potential. Pharmacol Ther 84: 133\u2013156.", "journal-title": "Pharmacol Ther"}, {"key": "BF1301305_CR15", "doi-asserted-by": "publisher", "first-page": "358", "DOI": "10.1038/335358a0", "volume": "335", "author": "A Fargin", "year": "1988", "unstructured": "Fargin A, Raymond JR, Lohse MJ, Kobilka BK, Caron MG, Lefkowitz RJ (1988). The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature 335: 358\u2013360.", "journal-title": "Nature"}, {"key": "BF1301305_CR16", "doi-asserted-by": "publisher", "first-page": "734", "DOI": "10.1124/jpet.102.045716", "volume": "306", "author": "M Filip", "year": "2003", "unstructured": "Filip M, Cunningham KA (2003). Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin(2C) (5-HT(2C)) receptors in rat prefrontal cortex. J Pharmacol Exp Ther 306: 734\u2013743.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF1301305_CR17", "doi-asserted-by": "publisher", "first-page": "1371", "DOI": "10.1136/bmj.321.7273.1371", "volume": "321", "author": "J Geddes", "year": "2000", "unstructured": "Geddes J, Freemantle N, Harrison P, Bebbington P (2000). Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ 321: 1371\u20131376.", "journal-title": "BMJ"}, {"key": "BF1301305_CR18", "first-page": "1183", "volume": "295", "author": "AJ Grottick", "year": "2000", "unstructured": "Grottick AJ, Fletcher PJ, Higgins GA (2000). Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior. J Pharmacol Exp Ther 295: 1183\u20131191.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF1301305_CR19", "doi-asserted-by": "publisher", "first-page": "4S", "DOI": "10.1097/00004714-199502001-00002", "volume": "15", "author": "M Huttunen", "year": "1995", "unstructured": "Huttunen M (1995). The evolution of the serotonin-dopamine antagonist concept. J Clin Psychopharmacol 15: 4S\u201310S.", "journal-title": "J Clin Psychopharmacol"}, {"key": "BF1301305_CR20", "doi-asserted-by": "publisher", "first-page": "558", "DOI": "10.1126/science.3399891", "volume": "241", "author": "D Julius", "year": "1988", "unstructured": "Julius D, MacDermott AB, Axel R, Jessell TM (1988). Molecular characterization of a functional cDNA encoding the serotonin 1c receptor. Science 241: 558\u2013564.", "journal-title": "Science"}, {"key": "BF1301305_CR21", "author": "HI Kaplan", "first-page": "940", "year": "1994", "unstructured": "Kaplan HI, Sadock BJ, Grebb JA (1994). Dopamine receptor antagonists (antipsychotics). In: Cancro R, Gabbard GO, Jones RM, Kaplan PM, Pataki CS, Sadock VA (eds). Synopsis of Psychiatry. Williams and Wilkins: Philadelphia. pp 940\u2013960.", "volume-title": "Synopsis of Psychiatry"}, {"key": "BF1301305_CR22", "doi-asserted-by": "publisher", "first-page": "873", "DOI": "10.1016/S0006-3223(01)01251-3", "volume": "50", "author": "S Kapur", "year": "2001", "unstructured": "Kapur S, Remington G (2001). Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biol Psychiatry 50: 873\u2013883.", "journal-title": "Biol Psychiatry"}, {"key": "BF1301305_CR23", "doi-asserted-by": "publisher", "first-page": "360", "DOI": "10.1176/appi.ajp.158.3.360", "volume": "158", "author": "S Kapur", "year": "2001", "unstructured": "Kapur S, Seeman P (2001). Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics? A new hypothesis. Am J Psychiatry 158: 360\u2013369.", "journal-title": "Am J Psychiatry"}, {"key": "BF1301305_CR24", "doi-asserted-by": "publisher", "first-page": "120", "DOI": "10.1124/mol.58.1.120", "volume": "58", "author": "SP Lee", "year": "2000", "unstructured": "Lee SP, O'Dowd BF, Ng GY, Varghese G, Akil H, Mansour A et al (2000). Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell. Mol Pharmacol 58: 120\u2013128.", "journal-title": "Mol Pharmacol"}, {"key": "BF1301305_CR25", "doi-asserted-by": "publisher", "first-page": "51", "DOI": "10.1016/S0920-9964(98)00105-4", "volume": "35", "author": "S Leucht", "year": "1999", "unstructured": "Leucht S, Pitschel-Walz G, Abraham D, Kissling W (1999). Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials. Schizophr Res 35: 51\u201368.", "journal-title": "Schizophr Res"}, {"key": "BF1301305_CR26", "doi-asserted-by": "publisher", "first-page": "S40", "DOI": "10.1007/BF02245006", "volume": "112", "author": "JE Leysen", "year": "1993", "unstructured": "Leysen JE, Janssen PM, Schotte A, Luyten WH, Megens AA (1993). Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors. Psychopharmacology (Berlin) 112: S40\u2013S54.", "journal-title": "Psychopharmacology (Berlin)"}, {"key": "BF1301305_CR27", "doi-asserted-by": "publisher", "first-page": "12", "DOI": "10.1002/syn.1095", "volume": "42", "author": "JF Lopez-Gimenez", "year": "2001", "unstructured": "Lopez-Gimenez JF, Mengod G, Palacios JM, Vilaro MT (2001). Regional distribution and cellular localization of 5-HT2C receptor mRNA in monkey brain: comparison with mesulergine binding sites and choline acetyltransferase mRNA. Synapse 42: 12\u201326.", "journal-title": "Synapse"}, {"key": "BF1301305_CR28", "doi-asserted-by": "publisher", "first-page": "486", "DOI": "10.1124/jpet.106.106989", "volume": "320", "author": "KL Marquis", "year": "2007", "unstructured": "Marquis KL, Sabb AL, Logue SF, Brennan JA, Piesla MJ, Comery TA et al (2007). WAY-163909 ((7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b]diazepino[6,7,1hi]indole): a novel 5-HT2C receptor selective agonist with preclinical antipsychotic-like activity. J Pharmacol Exp Ther 320: 486\u2013496.", "journal-title": "J Pharmacol Exp Ther"}, {"issue": "Suppl", "key": "BF1301305_CR29", "doi-asserted-by": "publisher", "first-page": "S18", "DOI": "10.1007/BF00442554", "volume": "99", "author": "HY Meltzer", "year": "1989", "unstructured": "Meltzer HY (1989). Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology (Berlin) 99 (Suppl): S18\u2013S27.", "journal-title": "Psychopharmacology (Berlin)"}, {"key": "BF1301305_CR30", "doi-asserted-by": "publisher", "first-page": "2S", "DOI": "10.1097/00004714-199502001-00001", "volume": "15", "author": "HY Meltzer", "year": "1995", "unstructured": "Meltzer HY (1995). The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics. J Clin Psychopharmacol 15: 2S\u20133S.", "journal-title": "J Clin Psychopharmacol"}, {"key": "BF1301305_CR31", "doi-asserted-by": "publisher", "first-page": "106S", "DOI": "10.1016/S0893-133X(99)00046-9", "volume": "21", "author": "HY Meltzer", "year": "1999", "unstructured": "Meltzer HY (1999). The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21: 106S\u2013115S.", "journal-title": "Neuropsychopharmacology"}, {"key": "BF1301305_CR32", "doi-asserted-by": "publisher", "first-page": "1159", "DOI": "10.1016/j.pnpbp.2003.09.010", "volume": "27", "author": "HY Meltzer", "year": "2003", "unstructured": "Meltzer HY, Li Z, Kaneda Y, Ichikawa J (2003). Serotonin receptors: their key role in drugs to treat schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27: 1159\u20131172.", "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry"}, {"key": "BF1301305_CR33", "first-page": "238", "volume": "251", "author": "HY Meltzer", "year": "1989", "unstructured": "Meltzer HY, Matsubara S, Lee JC (1989a). Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther 251: 238\u2013246.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF1301305_CR34", "first-page": "390", "volume": "25", "author": "HY Meltzer", "year": "1989", "unstructured": "Meltzer HY, Matsubara S, Lee JC (1989b). The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacol Bull 25: 390\u2013392.", "journal-title": "Psychopharmacol Bull"}, {"key": "BF1301305_CR35", "first-page": "853", "volume": "295", "author": "MJ Millan", "year": "2000", "unstructured": "Millan MJ (2000). Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors. J Pharmacol Exp Ther 295: 853\u2013861.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF1301305_CR36", "doi-asserted-by": "publisher", "first-page": "953", "DOI": "10.1016/S0028-3908(98)00078-1", "volume": "37", "author": "MJ Millan", "year": "1998", "unstructured": "Millan MJ, Dekeyne A, Gobert A (1998). Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 37: 953\u2013955.", "journal-title": "Neuropharmacology"}, {"key": "BF1301305_CR37", "doi-asserted-by": "publisher", "first-page": "568", "DOI": "10.1016/j.biopsych.2005.07.035", "volume": "59", "author": "S Navailles", "year": "2006", "unstructured": "Navailles S, De Deurwaerdere P, Spampinato U (2006). Clozapine and haloperidol differentially alter the constitutive activity of central serotonin2C receptors in vivo. Biol Psychiatry 59: 568\u2013575.", "journal-title": "Biol Psychiatry"}, {"key": "BF1301305_CR38", "doi-asserted-by": "publisher", "first-page": "29229", "DOI": "10.1074/jbc.272.46.29229", "volume": "272", "author": "EA Nimchinsky", "year": "1997", "unstructured": "Nimchinsky EA, Hof PR, Janssen WGM, Morrison JH, Schmauss C (1997). Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells. J Biol Chem 272: 29229\u201329237.", "journal-title": "J Biol Chem"}, {"key": "BF1301305_CR39", "doi-asserted-by": "publisher", "first-page": "9472", "DOI": "10.1074/jbc.274.14.9472", "volume": "274", "author": "CM Niswender", "year": "1999", "unstructured": "Niswender CM, Copeland SC, Herrick-Davis K, Emeson RB, Sanders-Bush E (1999). RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem 274: 9472\u20139478.", "journal-title": "J Biol Chem"}, {"key": "BF1301305_CR40", "doi-asserted-by": "publisher", "first-page": "93", "DOI": "10.1046/j.1471-4159.2002.00947.x", "volume": "82", "author": "L Pozzi", "year": "2002", "unstructured": "Pozzi L, Acconcia S, Ceglia I, Invernizzi RW, Samanin R (2002). Stimulation of 5-hydroxytryptamine (5-HT(2C)) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex. J Neurochem 82: 93\u2013100.", "journal-title": "J Neurochem"}, {"key": "BF1301305_CR41", "doi-asserted-by": "publisher", "first-page": "4135", "DOI": "10.1002/j.1460-2075.1988.tb03308.x", "volume": "7", "author": "DB Pritchett", "year": "1988", "unstructured": "Pritchett DB, Bach AW, Wozny M, Taleb O, Dal Toso R, Shih JC et al (1988). Structure and functional expression of cloned rat serotonin 5HT-2 receptor. EMBO J 7: 4135\u20134140.", "journal-title": "EMBO J"}, {"key": "BF1301305_CR42", "doi-asserted-by": "publisher", "first-page": "167", "DOI": "10.1016/0014-2999(94)90277-1", "volume": "271", "author": "P Protais", "year": "1994", "unstructured": "Protais P, Chagraoui A, Arbaoui J, Mocaer E (1994). Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents. Eur J Pharmacol 271: 167\u2013177.", "journal-title": "Eur J Pharmacol"}, {"key": "BF1301305_CR43", "first-page": "83", "volume": "299", "author": "L Rauser", "year": "2001", "unstructured": "Rauser L, Savage JE, Meltzer HY, Roth BL (2001). Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor. J Pharmacol Exp Ther 299: 83\u201389.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF1301305_CR44", "doi-asserted-by": "publisher", "first-page": "99", "DOI": "10.1016/j.pharmthera.2004.03.004", "volume": "102", "author": "BL Roth", "year": "2004", "unstructured": "Roth BL, Lopez E, Beischel S, Westkaemper RB, Evans JM (2004). Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discovery. Pharmacol Ther 102: 99\u2013110.", "journal-title": "Pharmacol Ther"}, {"key": "BF1301305_CR45", "doi-asserted-by": "publisher", "first-page": "30308", "DOI": "10.1074/jbc.M102297200", "volume": "276", "author": "M Scarselli", "year": "2001", "unstructured": "Scarselli M, Novi F, Schallmach E, Lin R, Baragli A, Colzi A et al (2001). D2/D3 dopamine receptor heterodimers exhibit unique functional properties. J Biol Chem 276: 30308\u201330314.", "journal-title": "J Biol Chem"}, {"key": "BF1301305_CR46", "first-page": "83", "volume": "280", "author": "H Schoemaker", "year": "1997", "unstructured": "Schoemaker H, Claustre Y, Fage D, Rouquier L, Chergui K, Curet O et al (1997). Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. J Pharmacol Exp Ther 280: 83\u201397.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "BF1301305_CR47", "first-page": "27", "volume": "47", "author": "P Seeman", "year": "2002", "unstructured": "Seeman P (2002). Atypical antipsychotics: mechanism of action. Can J Psychiatry 47: 27\u201338.", "journal-title": "Can J Psychiatry"}, {"key": "BF1301305_CR48", "doi-asserted-by": "publisher", "first-page": "93", "DOI": "10.1016/S0893-133X(96)00187-X", "volume": "16", "author": "P Seeman", "year": "1997", "unstructured": "Seeman P, Corbett R, Van Tol HH (1997). Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Neuropsychopharmacology 16: 93\u2013110.", "journal-title": "Neuropsychopharmacology"}, {"key": "BF1301305_CR49", "doi-asserted-by": "publisher", "first-page": "717", "DOI": "10.1038/261717a0", "volume": "261", "author": "P Seeman", "year": "1976", "unstructured": "Seeman P, Lee T, Chau-Wong M, Wong K (1976). Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261: 717\u2013719.", "journal-title": "Nature"}, {"key": "BF1301305_CR50", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1038/sj.mp.4000336", "volume": "3", "author": "P Seeman", "year": "1998", "unstructured": "Seeman P, Tallerico T (1998). Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Mol Psychiatry 3: 123\u2013134.", "journal-title": "Mol Psychiatry"}, {"key": "BF1301305_CR51", "doi-asserted-by": "publisher", "first-page": "146", "DOI": "10.1038/347146a0", "volume": "347", "author": "P Sokoloff", "year": "1990", "unstructured": "Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC (1990). Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347: 146\u2013151.", "journal-title": "Nature"}, {"key": "BF1301305_CR52", "first-page": "119", "volume": "53", "author": "PG Strange", "year": "2001", "unstructured": "Strange PG (2001). Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects. Pharmacol Rev 53: 119\u2013133.", "journal-title": "Pharmacol Rev"}, {"key": "BF1301305_CR53", "doi-asserted-by": "publisher", "first-page": "610", "DOI": "10.1038/350610a0", "volume": "350", "author": "HH Van Tol", "year": "1991", "unstructured": "Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB et al (1991). Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350: 610\u2013614.", "journal-title": "Nature"}, {"key": "BF1301305_CR54", "first-page": "107", "volume": "51", "author": "A Vuckovic", "year": "1990", "unstructured": "Vuckovic A, Cohen BM, Keck PEJ, Shedlack KJ (1990). Neuroleptic dosage regimens in psychotic inpatients: a retrospective comparison. J Clin Psychiatry 51: 107\u2013109.", "journal-title": "J Clin Psychiatry"}, {"key": "BF1301305_CR55", "doi-asserted-by": "publisher", "first-page": "179", "DOI": "10.1016/S0304-3940(98)00882-9", "volume": "258", "author": "A Vysokanov", "year": "1998", "unstructured": "Vysokanov A, Flores-Hernandez J, Surmeier DJ (1998). mRNAs for clozapine-sensitive receptors co-localize in rat prefrontal cortex neurons. Neurosci Lett 258: 179\u2013182.", "journal-title": "Neurosci Lett"}, {"key": "BF1301305_CR56", "first-page": "200", "volume": "48", "author": "RS Westphal", "year": "1995", "unstructured": "Westphal RS, Backstrom JR, Sanders-Bush E (1995). Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization. Mol Pharmacol 48: 200\u2013205.", "journal-title": "Mol Pharmacol"}, {"key": "BF1301305_CR57", "doi-asserted-by": "publisher", "first-page": "445", "DOI": "10.2174/187152706777950693", "volume": "5", "author": "MD Wood", "year": "2006", "unstructured": "Wood MD, Scott C, Clarke K, Cato KJ, Patel N, Heath J et al (2006). Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade. CNS Neurol Disord Drug Targets 5: 445\u2013452.", "journal-title": "CNS Neurol Disord Drug Targets"}, {"key": "BF1301305_CR58", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1016/S0014-5793(98)01588-9", "volume": "441", "author": "P Zawarynski", "year": "1998", "unstructured": "Zawarynski P, Tallerico T, Seeman P, Lee SP, O'Dowd BF, George SR (1998). Dopamine D2 receptor dimers in human and rat brain. FEBS Lett 441: 383\u2013386.", "journal-title": "FEBS Lett"}, {"key": "BF1301305_CR59", "doi-asserted-by": "publisher", "first-page": "782", "DOI": "10.1176/ajp.154.6.782", "volume": "154", "author": "DL Zimbroff", "year": "1997", "unstructured": "Zimbroff DL, Kane JM, Tamminga CA, Daniel DG, Mack RJ, Wozniak PJ et al (1997). Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group. Am J Psychiatry 154: 782\u2013791.", "journal-title": "Am J Psychiatry"}], "container-title": ["Neuropsychopharmacology"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/1301305.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1301305", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/1301305.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 15]], "date-time": "2019-03-15T19:51:35Z", "timestamp": 1552679495000}, "score": 28.302975, "issued": {"date-parts": [[2007, 1, 24]]}, "references-count": 59, "journal-issue": {"published-print": {"date-parts": [[2007, 8]]}, "issue": "8"}, "alternative-id": ["BF1301305"], "URL": "http://dx.doi.org/10.1038/sj.npp.1301305", "relation": {"cites": []}, "ISSN": ["0893-133X", "1740-634X"], "issn-type": [{"value": "0893-133X", "type": "print"}, {"value": "1740-634X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T18:42:54Z", "timestamp": 1575052974621}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1999, 2, 15]], "date-time": "1999-02-15T00:00:00Z", "timestamp": 919036800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Neural Transmission"], "published-print": {"date-parts": [[1999, 2, 15]]}, "DOI": "10.1007/s007020050142", "type": "journal-article", "created": {"date-parts": [[2002, 8, 25]], "date-time": "2002-08-25T09:09:23Z", "timestamp": 1030266563000}, "page": "75-105", "source": "Crossref", "is-referenced-by-count": 43, "title": ["Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters, and serotonin 1A receptors"], "prefix": "10.1007", "volume": "106", "author": [{"given": "A. R.", "family": "Ase", "sequence": "first", "affiliation": []}, {"given": "F.", "family": "Amdiss", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "H\u00e9bert", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Huang", "sequence": "additional", "affiliation": []}, {"given": "N. M.", "family": "van Gelder", "sequence": "additional", "affiliation": []}, {"given": "T. A.", "family": "Reader", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Journal of Neural Transmission"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s007020050142.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s007020050142/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s007020050142", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 29]], "date-time": "2019-05-29T04:30:38Z", "timestamp": 1559104238000}, "score": 27.172766, "issued": {"date-parts": [[1999, 2, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1999, 2, 15]]}, "issue": "1"}, "alternative-id": ["FNGFGALVRDE7U1J5"], "URL": "http://dx.doi.org/10.1007/s007020050142", "ISSN": ["0300-9564", "1435-1463"], "issn-type": [{"value": "0300-9564", "type": "print"}, {"value": "1435-1463", "type": "electronic"}], "subject": ["Biological Psychiatry", "Neurology", "Psychiatry and Mental health", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T07:12:12Z", "timestamp": 1574233932457}, "reference-count": 42, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 10197, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Neurochem"], "published-print": {"date-parts": [[1987, 10]]}, "DOI": "10.1111/j.1471-4159.1987.tb10026.x", "type": "journal-article", "created": {"date-parts": [[2006, 10, 5]], "date-time": "2006-10-05T20:36:24Z", "timestamp": 1160080584000}, "page": "1316-1323", "source": "Crossref", "is-referenced-by-count": 14, "title": ["Synthesis and High Affinity Uptake of Serotonin and Dopamine by Human Y79 Retinoblastoma Cells"], "prefix": "10.1111", "volume": "49", "author": [{"given": "Mark A.", "family": "Yorek", "sequence": "first", "affiliation": []}, {"given": "David K.", "family": "Strom", "sequence": "additional", "affiliation": []}, {"given": "Arthur A.", "family": "Spector", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "b1_1347", "author": "Brecha N.", "first-page": "85", "year": "1983", "volume-title": "Neurochemical Anatomy"}, {"key": "b2_1348", "author": "Brecha N. C.", "volume": "25", "first-page": "66", "year": "1984", "journal-title": "Invest. Ophthalmol. Vis. Sci."}, {"key": "b3_1349", "author": "Cleland W. W.", "first-page": "1", "year": "1967", "volume-title": "Advances in Enzymology, Vol 29"}, {"key": "b4_1350", "author": "Cohen J.", "volume": "43", "first-page": "2725", "year": "1984", "journal-title": "Fed. Proc."}, {"key": "b5_1351", "author": "Ehinger B.", "first-page": "145", "year": "1976", "volume-title": "Transmitters in the Visual Process", "DOI": "10.1016/B978-0-08-020907-4.50011-X", "doi-asserted-by": "crossref"}, {"key": "b6_1352", "DOI": "10.1016/0014-4835(78)90147-1", "doi-asserted-by": "publisher"}, {"key": "b7_1353", "DOI": "10.1007/BF00233913", "doi-asserted-by": "publisher"}, {"key": "b8_1354", "author": "Ehinger B.", "volume": "33", "first-page": "663", "year": "1981", "journal-title": "Exp. Eye Res.", "DOI": "10.1016/S0014-4835(81)80106-6", "doi-asserted-by": "crossref"}, {"key": "b9_1355", "DOI": "10.1007/BF01243425", "doi-asserted-by": "publisher"}, {"key": "b10_1356", "author": "Floren I.", "volume": "19", "first-page": "117", "year": "1980", "journal-title": "Invest. Ophthalmol. Vis. Sci."}, {"key": "b11_1357", "DOI": "10.1016/0024-3205(84)90184-X", "doi-asserted-by": "publisher"}, {"key": "b12_1358", "author": "Herrero E.", "volume": "40", "first-page": "332", "year": "1983", "journal-title": "J. Neurochem.", "DOI": "10.1111/j.1471-4159.1983.tb11287.x", "doi-asserted-by": "crossref"}, {"key": "b13_1359", "author": "Hyman B. T.", "volume": "37", "first-page": "60", "year": "1981", "journal-title": "J. Neumchem.", "DOI": "10.1111/j.1471-4159.1981.tb05291.x", "doi-asserted-by": "crossref"}, {"key": "b14_1360", "author": "Hyman B. T.", "volume": "38", "first-page": "650", "year": "1982", "journal-title": "J. Neurochem.", "DOI": "10.1111/j.1471-4159.1982.tb08680.x", "doi-asserted-by": "crossref"}, {"key": "b15_1361", "DOI": "10.1016/0042-6989(83)90104-9", "doi-asserted-by": "publisher"}, {"key": "b16_1362", "author": "Kaduce T. L.", "volume": "252", "first-page": "6624", "year": "1977", "journal-title": "J. Biol. Chem."}, {"key": "b17_1363", "author": "Katz D. M.", "volume": "5", "first-page": "1901", "year": "1985", "journal-title": "J. Neurosci.", "DOI": "10.1523/JNEUROSCI.05-07-01901.1985", "doi-asserted-by": "crossref"}, {"key": "b18_1364", "author": "Knowles R. G.", "volume": "42", "first-page": "663", "year": "1984", "journal-title": "J Neurochem.", "DOI": "10.1111/j.1471-4159.1984.tb02734.x", "doi-asserted-by": "crossref"}, {"key": "b19_1365", "DOI": "10.1038/307471a0", "doi-asserted-by": "publisher"}, {"key": "b20_1366", "author": "Kyritsis A. P.", "volume": "27", "first-page": "1760", "year": "1986", "journal-title": "Invest. Ophthal. Vis. Sci."}, {"key": "b21_1367", "author": "Lam D. M. K.", "volume": "1", "first-page": "1117", "year": "1981", "journal-title": "J. Neurosci", "DOI": "10.1523/JNEUROSCI.01-10-01117.1981", "doi-asserted-by": "crossref"}, {"key": "b22_1368", "DOI": "10.1016/0003-2697(72)90291-6", "doi-asserted-by": "publisher"}, {"key": "b23_1369", "author": "Nakaki T.", "volume": "45", "first-page": "920", "year": "1985", "journal-title": "J. Neurochem.", "DOI": "10.1111/j.1471-4159.1985.tb04081.x", "doi-asserted-by": "crossref"}, {"key": "b24_1370", "author": "Ofori S.", "volume": "47", "first-page": "1199", "year": "1986", "journal-title": "J. Neurochem.", "DOI": "10.1111/j.1471-4159.1986.tb00740.x", "doi-asserted-by": "crossref"}, {"key": "b25_1371", "DOI": "10.1016/0006-8993(80)90799-4", "doi-asserted-by": "publisher"}, {"key": "b26_1372", "DOI": "10.1016/0014-4835(80)90088-3", "doi-asserted-by": "publisher"}, {"key": "b27_1373", "author": "Osborne N. N.", "volume": "39", "first-page": "1519", "year": "1982", "journal-title": "J. Neurochem.", "DOI": "10.1111/j.1471-4159.1982.tb07984.x", "doi-asserted-by": "crossref"}, {"key": "b28_1374", "author": "Parkinson D.", "volume": "1", "first-page": "1211", "year": "1981", "journal-title": "J. Neurosci.", "DOI": "10.1523/JNEUROSCI.01-11-01211.1981", "doi-asserted-by": "crossref"}, {"key": "b29_1375", "author": "Redburn D. A.", "volume": "43", "first-page": "2699", "year": "1984", "journal-title": "Fed. Proc."}, {"key": "b30_1376", "DOI": "10.1016/0042-6989(81)90055-9", "doi-asserted-by": "publisher"}, {"key": "b31_1377", "author": "Reid T. W.", "volume": "53", "first-page": "347", "year": "1974", "journal-title": "J. Natl. Cancer Inst.", "DOI": "10.1093/jnci/53.2.347", "doi-asserted-by": "crossref"}, {"key": "b32_1378", "author": "Sang D. N.", "first-page": "172", "year": "1978", "volume-title": "Ocular and Adnexal Tumors"}, {"key": "b33_1379", "author": "Sarthy P. V.", "volume": "32", "first-page": "1269", "year": "1979", "journal-title": "J. Neurochem", "DOI": "10.1111/j.1471-4159.1979.tb11054.x", "doi-asserted-by": "crossref"}, {"key": "b34_1380", "DOI": "10.1016/0014-4835(79)90105-2", "doi-asserted-by": "publisher"}, {"key": "b35_1381", "DOI": "10.1016/0042-6989(80)90135-2", "doi-asserted-by": "publisher"}, {"key": "b36_1382", "author": "Tsokos M.", "volume": "123", "first-page": "542", "year": "1986", "journal-title": "Am. J. Pathol."}, {"key": "b37_1383", "author": "Vaney D. I.", "volume": "233", "first-page": "444", "year": "1986", "journal-title": "Science", "DOI": "10.1126/science.3726538", "doi-asserted-by": "crossref"}, {"key": "b38_1384", "author": "Wagner J.", "volume": "38", "first-page": "1241", "year": "1982", "journal-title": "J. Neurochem.", "DOI": "10.1111/j.1471-4159.1982.tb07897.x", "doi-asserted-by": "crossref"}, {"key": "b39_1385", "author": "Yorek M. A.", "volume": "40", "first-page": "70", "year": "1983", "journal-title": "J. Neurochem.", "DOI": "10.1111/j.1471-4159.1983.tb12654.x", "doi-asserted-by": "crossref"}, {"key": "b40_1386", "author": "Yorek M. A.", "volume": "41", "first-page": "809", "year": "1983", "journal-title": "J. Neurochem.", "DOI": "10.1111/j.1471-4159.1983.tb04812.x", "doi-asserted-by": "crossref"}, {"key": "b41_1387", "author": "Yorek M. A.", "first-page": "361", "year": "1985", "volume-title": "Taurine: Biological actions and clinical perspectives"}, {"key": "b42_1388", "author": "Yorek M. A.", "volume": "42", "first-page": "254", "year": "1984", "journal-title": "J. Neurochem.", "DOI": "10.1111/j.1471-4159.1984.tb09726.x", "doi-asserted-by": "crossref"}], "container-title": ["Journal of Neurochemistry"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1471-4159.1987.tb10026.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 13]], "date-time": "2019-01-13T18:15:59Z", "timestamp": 1547403359000}, "score": 27.141256, "issued": {"date-parts": [[1987, 10]]}, "references-count": 42, "journal-issue": {"published-print": {"date-parts": [[1987, 10]]}, "issue": "4"}, "alternative-id": ["10.1111/j.1471-4159.1987.tb10026.x"], "URL": "http://dx.doi.org/10.1111/j.1471-4159.1987.tb10026.x", "relation": {"cites": []}, "ISSN": ["0022-3042", "1471-4159"], "issn-type": [{"value": "0022-3042", "type": "print"}, {"value": "1471-4159", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T09:17:36Z", "timestamp": 1575191856467}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2003, 2, 1]], "date-time": "2003-02-01T00:00:00Z", "timestamp": 1044057600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Naunyn-Schmiedeberg's Arch Pharmacol"], "published-print": {"date-parts": [[2003, 2]]}, "DOI": "10.1007/s00210-002-0665-4", "type": "journal-article", "created": {"date-parts": [[2005, 12, 7]], "date-time": "2005-12-07T19:16:56Z", "timestamp": 1133983016000}, "page": "134-139", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Reduction of extracellular dopamine and metabolite concentrations in rat striatum by low doses of acute cyamemazine"], "prefix": "10.1007", "volume": "367", "author": [{"given": "J.", "family": "Peinado", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Hameg", "sequence": "additional", "affiliation": []}, {"given": "R. P.", "family": "Garay", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Bayle", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Nuss", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Dib", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Naunyn-Schmiedeberg's Archives of Pharmacology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00210-002-0665-4.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00210-002-0665-4/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00210-002-0665-4", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 23]], "date-time": "2019-05-23T20:01:53Z", "timestamp": 1558641713000}, "score": 27.070679, "issued": {"date-parts": [[2003, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2003, 2]]}, "issue": "2"}, "alternative-id": ["0665"], "URL": "http://dx.doi.org/10.1007/s00210-002-0665-4", "ISSN": ["0028-1298"], "issn-type": [{"value": "0028-1298", "type": "print"}], "subject": ["Pharmacology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T07:30:19Z", "timestamp": 1574235019768}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "Supplement 3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["International Clinical Psychopharmacology"], "published-print": {"date-parts": [[1995, 9]]}, "DOI": "10.1097/00004850-199509000-00011", "type": "journal-article", "created": {"date-parts": [[2006, 10, 10]], "date-time": "2006-10-10T09:38:30Z", "timestamp": 1160473110000}, "page": "81-85", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man"], "prefix": "10.1097", "volume": "10", "author": [{"given": "S", "family": "Nyberg", "sequence": "first", "affiliation": []}, {"given": "A L", "family": "Nordstrom", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Halldin", "sequence": "additional", "affiliation": []}, {"given": "L", "family": "Farde", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["International Clinical Psychopharmacology"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T07:42:09Z", "timestamp": 1518162129000}, "score": 26.476639, "subtitle": [""], "issued": {"date-parts": [[1995, 9]]}, "references-count": 0, "journal-issue": {"issue": "Supplement 3"}, "URL": "http://dx.doi.org/10.1097/00004850-199509000-00011", "ISSN": ["0268-1315"], "issn-type": [{"value": "0268-1315", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T11:34:32Z", "timestamp": 1574249672807}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["International Clinical Psychopharmacology"], "published-print": {"date-parts": [[1995, 9]]}, "DOI": "10.1097/00004850-199509003-00011", "type": "journal-article", "created": {"date-parts": [[2006, 12, 13]], "date-time": "2006-12-13T09:48:04Z", "timestamp": 1166003284000}, "page": "81-86", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man"], "prefix": "10.1097", "volume": "10", "author": [{"given": "S.", "family": "Nyberg", "sequence": "first", "affiliation": []}, {"given": "A. -L.", "family": "Nordstr\u00f6m", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Halldin", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Farde", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["International Clinical Psychopharmacology"], "language": "en", "deposited": {"date-parts": [[2018, 2, 8]], "date-time": "2018-02-08T21:48:25Z", "timestamp": 1518126505000}, "score": 26.476639, "subtitle": [""], "issued": {"date-parts": [[1995, 9]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1097/00004850-199509003-00011", "ISSN": ["0268-1315"], "issn-type": [{"value": "0268-1315", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}